All conditions

Hypertension

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

3627
Trials on record
343
Recruiting now
6
Australian sites
13
Phase 3 trials
5
PBS medicines
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Hypertension →

Get alerts when Hypertension trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Hypertension (High Blood Pressure)

Hypertension is the medical term for high blood pressure. Blood pressure is the force that your blood puts on the walls of your arteries as your heart pumps it around your body. When that pressure stays consistently too high over time, it puts extra strain on your heart, blood vessels, and organs like your kidneys and brain. Most people with hypertension do not feel any different day to day, which is why it is sometimes called a "silent" condition — you often cannot tell it is there without measuring it.

Hypertension is very common in Australia. According to the Australian Bureau of Statistics, around one in three Australian adults has high blood pressure, and the risk increases with age. It affects both men and women, though it becomes particularly common in older Australians. Many people are unaware they have it until it is picked up during a routine check-up or appointment for something else entirely.

When it comes to managing hypertension, doctors in Australia generally look at a combination of approaches. Lifestyle changes are typically part of the picture — things like physical activity, diet, reducing salt intake, limiting alcohol, and not smoking. For many people, medication is also recommended, and there are several different types that doctors can consider depending on the individual. Regular monitoring of blood pressure, whether at a clinic or at home, is also a common part of ongoing care. A GP or specialist is the right person to talk to about what options make sense for any particular person.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Hypertension in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

PBS-subsidised medicines for Hypertension

5 medicines listed on the PBS for Hypertension. Filter by authority type, or open the full table below.

What the authority types mean Unrestricted: no clinical criteria; a doctor can prescribe it on the PBS for any appropriate use. Restricted benefit: subsidised only for the specific conditions or uses set out by the PBS. Streamlined authority: restricted, but the doctor does not need prior approval; they record a streamlined authority code confirming you meet the criteria. Authority required: restricted, and the doctor must get prior approval from Services Australia (by phone or online) before it is subsidised. Source: Pharmaceutical Benefits Scheme (pbs.gov.au).
Full PBS medicines table 5 listed

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. Prices shown are the PBS-determined dispensed price. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest.

Medicine Brand(s) Listed for
Amlodipine + valsartan + hydrochlorothiazide Amlodipine/Valsartan/HCT Novartis 10/160/25, Amlodipine/Valsartan/HCT Novartis 5/160/12.5, Amlodipine/Valsartan/HCT Novartis 10/160/12.5 +2 more Hypertension AU$10.72 Restricted benefit
Methyldopa Hydopa Hypertension AU$8.18 Authority required
Moxonidine Moxonidine GX Hypertension AU$4 Restricted benefit
Olmesartan + amlodipine + hydrochlorothiazide Sevikar HCT 20/5/12.5, Sevikar HCT 40/10/12.5, Sevikar HCT 40/5/25 +2 more Hypertension AU$5.57 Restricted benefit
Minoxidil Loniten refractory hypertension Severe AU$28.76 Restricted benefit

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Research pipeline

Where trials for Hypertension currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Hypertension.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Hypertension by country. Australia is highlighted.

Showing the top 10 of 62 countries with trial sites.

Clinical trials for Hypertension

Showing 343 of 343 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT06059638 · Orchestra BioMed, Inc Not Applicable · 15 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇦🇺 AU🇧🇪 BE🇨🇳 CN🇨🇿 CZ🇫🇷 FR🇩🇪 DE🇭🇺 HU🇮🇹 IT +7 more

**Who might be able to join this trial:** - People who have been diagnosed with a condition requiring a dual-chamber pacemaker, or who are already planning to receive one — specifically a Medtronic Astra/Azure model - People who are currently on a stable medication routine to manage high blood pressure, including at l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT06907147 · Medtronic Vascular Not Applicable · 6 countries Recruiting
Recruiting Not Applicable Est. completion 22 December 2029
🇦🇺 AU🇩🇪 DE🇬🇷 GR🇮🇪 IE🇨🇭 CH🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 80 years old - People who have been diagnosed with high blood pressure, with a clinic reading showing the top number at 150 or above but below 180, and the bottom number at 90 or above - People whose 24-hour blood pressure monitor (worn to record readings th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT07181109 · Alnylam Pharmaceuticals Phase 3 · 34 countries Recruiting
Recruiting Phase 3 Est. completion 30 September 2030
🇦🇷 AR🇦🇺 AU🇦🇹 AT🇧🇪 BE🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇱 CL +26 more

Who might be able to join this trial: - People who are 18 years of age or older and have an established heart or blood vessel disease (such as coronary artery disease, stroke-related artery disease, or peripheral artery disease). - People who are 55 years of age or older and are considered at high risk for heart or blo...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07282171 · Comanche Biopharma Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 March 2027
🇦🇺 AU

Who might be able to join this trial: - People who are pregnant and currently in hospital with a condition called preeclampsia (high blood pressure after 20 weeks of pregnancy, along with protein in the urine or signs that organs such as the kidneys or liver are not working normally) - People who are expected to stay i...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07428473 · Monash University Phase 1 · 2 countries Recruiting
Recruiting Phase 1 Est. completion 30 December 2028
🇦🇺 AU🇳🇿 NZ

Who might be able to join this trial: - People who have higher-than-normal levels of LDL cholesterol (sometimes called "bad" cholesterol) in their blood, whether or not they are currently taking medication to lower it - People who are willing and able to agree to participate before any study activities begin, and who a...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07555574 · Center for Eye Research Australia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2028
🇦🇺 AU

Who might be able to join this trial: - Adults aged 18 years or older - People who are able to give their informed consent to participate - People who are willing and able to attend a study visit at the Centre for Eye Research Australia - People who have been diagnosed with a retinal or optic nerve disease, such as dia...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00932139 · University of California, Irvine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

Who might be able to join this trial: - People who have mild coronary (heart) disease and no significant abnormalities on a resting heart tracing (ECG) that would suggest reduced blood flow to the heart. - People who have high blood pressure, whether or not they are currently taking medication to manage it. Who may no...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02132741 · University of Edinburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇬🇧 GB

**Who might be able to join this trial:** - People who are male or female - People aged between 18 and 80 years old - People with a body mass index (a measure of body weight relative to height) of 35 or below - For people with high blood pressure: those whose blood pressure reads 140/90 or higher, or who are already ta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02211365 · Federico II University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2017
🇮🇹 IT

"Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with high blood pressure (hypertension) Who may not be able to join: - People who decline to sign the informed consent form (a document agreeing to take part in the trial) Important: Always verify eligibility with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02391519 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - Women who are scheduled to have a planned caesarean delivery at University of Colorado Hospital (located in Denver, at 1,600 metres elevation) or St. Anthony's Summit Medical Center (located in Summit County, at 3,000 metres elevation). - Women whose caesarean delivery is planned...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02578810 · Suez Canal University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇲🇾 MY

"Who might be able to join this trial: - People who are pregnant, at any stage of pregnancy (first, second, or third trimester) - People who have eclampsia (a serious condition during pregnancy that causes seizures) - People who have pre-eclampsia (a condition during pregnancy involving high blood pressure and other sy...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02610413 · National Cancer Institute (NCI) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2100
🇺🇸 US

Who might be able to join this trial: - People of European American background who have DNA samples available and have been identified as either a "case" or "control" participant for this study - People who developed severe high blood pressure (graded 3 or 4 out of 4 in severity) as a side effect while being treated wi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02648009 · Sunnybrook Health Sciences Centre Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 April 2027
🇨🇦 CA

Who might be able to join this trial: - People must provide written consent to participate. - For Arm 1, participants must be between 19 and 50 years old; for Arm 2, between 30 and 75 years old. - Some participants in Group 2 must have a condition where the heart's left pumping chamber has become thickened and enlarged...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT02744365 · CHU de Quebec-Universite Laval Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2025
🇨🇦 CA

Who might be able to join this trial: - The inclusion criteria are specific to each individual study within this trial (confirm with trial site for details). Who may not be able to join: - Women who are pregnant and under 18 years old at the time of joining the study. - Women where no fetal heartbeat is detected at th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02770066 · University of Aarhus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2030
🇩🇰 DK

Who might be able to join this trial: - People who have high blood pressure that remains uncontrolled despite taking three or more blood pressure medications (including a water tablet, if tolerated) at the highest appropriate doses, confirmed by a 24-hour blood pressure monitoring test, with an average daytime reading...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03206814 · Istituto Auxologico Italiano Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇦🇷 AR🇨🇳 CN

**Who might be able to join this trial:** - Men and women between 18 and 80 years of age - People with high blood pressure that is not well controlled, whether or not they are currently being treated for it — specifically, a clinic blood pressure reading of 140/90 mmHg or higher, and an average 24-hour blood pressure m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03313024 · Charite University, Berlin, Germany Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇩🇪 DE

Who might be able to join this trial: - Healthy pregnant women who have given their informed consent to participate - Pregnant women who have been diagnosed with preeclampsia, gestational hypertension, or gestational diabetes Who may not be able to join: - People who have an active infection - People with a history of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03374215 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDD... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** **Main study:** - Adults aged 18 to 70 years who describe their race as Black. - People who have signs or evidence suggesting a condition called primary aldosteronism (for example, high blood pressure, low potassium levels, a known adrenal gland nodule, or certain abnormal blo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03470467 · Ictal Group Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been diagnosed with Posterior Reversible Encephalopathy Syndrome (PRES) — a brain condition that involves a combination of symptoms such as confusion or reduced consciousness, seizures, headaches, vision problems, nausea or vomi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03496792 · Milton S. Hershey Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are able to give their own informed consent to take part - People of any race or ethnicity - People who are fluent in both written and spoken English - People whose health history and physical examination do not reveal any of the exclusion conditions listed below...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03509272 · Hasselt University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇧🇪 BE

"Who might be able to join this trial: - People who are more than 10 weeks pregnant, whether this is their first pregnancy or they have had previous pregnancies Who may not be able to join: - People who are less than 10 weeks pregnant - People whose unborn baby has been found to have a congenital malformation (a struc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03547856 · Yan Li Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇨🇳 CN

Who might be able to join this trial: - You are between 18 and 80 years old - You have been diagnosed with high blood pressure and are currently taking medication to lower it - You have had a 24-hour blood pressure monitoring test done using approved equipment - You are willing to share information about your health hi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03595267 · University of Manitoba Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇨🇦 CA

Who might be able to join this trial: - People between the ages of 10 and 80 years old may be screened for this trial, whether or not they have known risk factors for kidney disease, such as diabetes, high blood pressure, or a family history of kidney disease. Who may not be able to join: - There are no listed exclusi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03762499 · University of Oxford Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇬🇧 GB

Who might be able to join this trial: - You are willing and able to agree to take part in the study by signing a consent form. - You are a man or woman between 18 and 40 years old (at the time of your appointment at the hypertension clinic). - You have been referred to a Hypertension (high blood pressure) Clinic in Eng...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03781401 · Italian Institute of Telemedicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇮🇹 IT

Who might be able to join this trial: - People of any age and any sex who are being referred for ambulatory blood pressure monitoring (a test where a device measures blood pressure repeatedly over 24 hours or more) for standard medical reasons - People who are either taking blood pressure-lowering medication or not tak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03806283 · University of Wisconsin, Madison Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇺🇸 US

Who might be able to join this trial: - People who are female - People aged between 18 and 40 years old - People who are pregnant with a single baby, at a stage of pregnancy between 28 weeks and 0 days, and 41 weeks and 0 days, at the time of giving consent to join the trial - People who are having a caesarean section,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03821623 · Douglas Seals Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2025
🇺🇸 US

**Who might be able to join this trial:** - People who are able to give their informed consent to participate - People who are willing to be randomly assigned to a study group - People whose top blood pressure number (systolic) is between 120 and 159 mmHg - People with a body mass index (a measure of body weight relati...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04046523 · University of Minnesota Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2029
🇺🇸 US

Who might be able to join this trial: - You must be able to sit still and keep your eyes focused on a target in the testing device. - If you are in the group being monitored for brain pressure (ICP), you must already have a brain pressure monitoring probe in place for your medical care. Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04064177 · Imperial College Healthcare NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇬🇧 GB

Who might be able to join this trial: - Healthy full-term newborn babies in the postnatal ward who are within the first 72 hours of life - Full-term or premature newborn babies (including those with restricted growth before birth) who have been admitted to the neonatal unit - Babies whose parents or guardians have give...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04126785 · Universidade Estadual Paulista Júlio de Mesquita Filho Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇧🇷 BR

**Who might be able to join this trial:** - People aged 60 years or older - People who have been diagnosed with high blood pressure (stage 1 or 2) for at least 6 months - People who have been taking blood pressure medication with no change in dose for at least the past 3 months - People whose blood pressure reading in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04140578 · Taipei Veterans General Hospital, Taiwan Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2030
🇹🇼 TW

Who might be able to join this trial: - People who have liver cirrhosis and/or liver cancer (hepatoma) - People aged between 20 and 85 years old who have had endoscopic treatment where gastric varices (enlarged veins in the stomach) were present, either without esophageal varices or where the gastric varices were large...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04160533 · National Medical Research Center for Cardiology, Ministry of Health of... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇷🇺 RU

"Who might be able to join this trial: - People who have been diagnosed with arterial hypertension (high blood pressure) Who may not be able to join: - People who have not been diagnosed with arterial hypertension (high blood pressure) Important: Always verify eligibility with the trial site directly before applying....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04212455 · Guangdong Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2022
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with high blood pressure, which may include having a blood pressure reading of 140/90 mmHg or higher, currently taking medication to lower blood pressure, or having been told by a doctor that they have high...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04393519 · University Hospital, Bonn Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇩🇪 DE

Who might be able to join this trial: - You are scheduled to receive a TIPS procedure (a special shunt placed inside the liver to redirect blood flow) based on standard medical guidelines Who may not be able to join: - You have a medical reason that makes it unsafe or unsuitable for you to have a TIPS procedure (confi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04401982 · University of Maryland, Baltimore Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 17 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are at least 18 years old. - People who have been diagnosed with high eye pressure (ocular hypertension) or are considered a suspected glaucoma patient. - People who have not used any eye pressure-lowering medications (either eye drops or tablets) in the past 6 mon...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04439370 · University of Minnesota Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Women aged 35–49 or 50–70 who went through menopause before age 40 (called premature menopause) or at age 45 or younger (called early menopause) - Women aged 35–49 who have not yet reached menopause (still having periods) - Women aged 50–70 who went through menopause at the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04459806 · University of Milano Bicocca Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇮🇹 IT

Who might be able to join this trial: - People between 18 and 80 years of age - People who have been diagnosed with an acute brain injury, which includes bleeding in the brain (such as a blood clot within the brain or bleeding around the brain) or a traumatic brain injury caused by physical impact - People who already...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04502225 · Vanderbilt University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with autonomic failure (a condition where the nervous system doesn't properly control automatic body functions) and also have high blood pressure while lying down - People of any racial background, male or female, aged between 18 and 85 years Who m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04530760 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇫🇷 FR

Who might be able to join this trial: - Adults (18 years or older) - People who have cirrhosis (a condition where the liver is scarred and not working properly) - People who are on a breathing machine (ventilator) through a tube placed in the throat Who may not be able to join: - People who are pregnant - People who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04532489 · Benjamin Viglianti Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who have no known problems or diseases affecting their adrenal glands (small glands located above the kidneys), who would participate as healthy comparison subjects to help measure radiation levels from imaging Who may not be able to join: - People who are pregnant - Peop...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT04546126 · Benjamin Viglianti Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: **Groups 2 & 3 (Healthy Controls):** - People who have no known problems or conditions affecting their adrenal glands, who would participate as healthy comparison participants during hormone-related testing **Group 4:** - People who have been found to have abnormal hormone produc...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT04578301 · University Hospital, Bonn Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇩🇪 DE

**Who might be able to join this trial:** - Adults aged 18 or older, of any gender - People who have liver cirrhosis (diagnosed through a biopsy or a combination of clinical checks, blood tests, and imaging), or who do not have cirrhosis but do have high blood pressure in the portal vein of the liver (confirm with tria...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04613193 · Henrik Wiggers Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2031
🇩🇰 DK

**Who might be able to join this trial:** - People whose aortic valve measurements fall within a specific range, showing a narrowing of the valve (confirm with trial site for exact values) - People whose resting blood pressure reading is 127 mmHg or higher (measured using a specific blood pressure device called BP-TRU...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04651530 · Helsinki University Central Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇫🇮 FI

**Who might be able to join this trial:** - You have signed a form agreeing to take part in the study - You have been diagnosed with Normal Tension Glaucoma, which means your eye pressure has never been above 21 mmHg, your eye drainage angle is open, and there are specific signs of damage to the nerve fibres in your ey...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04669548 · Potrero Medical Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You have agreed to take part, either by signing a consent form or giving verbal consent as required. - You are 18 years old or older. - You are being monitored using a specific device called the Accuryn® Monitoring System during your procedure and time in the intensive care u...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04675216 · University of Valencia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇪🇸 ES

Who might be able to join this trial: - Adults aged 18 years or older - People who have a condition affecting the lower back part of the brain (called the posterior fossa), caused by a traumatic injury, a tumor, a stroke due to blocked blood flow, or bleeding in the brain - People who have a low level of consciousness,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04707105 · Second Affiliated Hospital, School of Medicine, Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older who are admitted to hospital with a primary intracerebral hemorrhage (bleeding inside the brain that was not caused by another underlying condition). **Who may not be able to join:** - People whose brain bleed was caused by another condition, such as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04715022 · University of Kansas Medical Center Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 August 2026
🇺🇸 US

Here is the eligibility information for this trial in plain English: **Who might be able to join this trial:** - You have a Body Mass Index (BMI) over 30, which is classified as obese - You are between 35 and 65 years old - You are willing and able to stop taking any Vitamin C, Vitamin E, or omega-3/fish oil supplemen...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04715568 · University of California, San Francisco Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are able to understand the study and agree to participate in writing. - Adults aged 40 years or older. - People who have worked in a job where they were regularly exposed to other people's tobacco smoke for at least 5 years — for example, flight attendants who wor...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04720690 · Imperial College Healthcare NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇬🇧 GB

**Who might be able to join this trial:** - Healthy full-term newborns, including those born smaller than expected for their stage of pregnancy, who are in the postnatal ward - Full-term or premature newborns, including those born smaller than expected for their stage of pregnancy, who have been admitted to the neonata...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04753840 · Henan Institute of Cardiovascular Epidemiology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with mild high blood pressure, meaning their top blood pressure number is between 140 and 159, and their bottom number is between 90 and 99 Who may not be able to join: - People who are unable to tolerate the arm compression procedure used in this...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04755153 · Northwestern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2027
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 89 years of age - People who are patients at one of the participating clinics, or who attend one of the participating churches, in the communities where the trial is taking place Who may not be able to join: - People under 18 years of age Important: Always...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04766866 · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Not Applicable · 9 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇧🇪 BE🇨🇴 CO🇨🇿 CZ Ecuador🇮🇳 IN🇲🇽 MX Panama🇵🇱 PL +1 more

Who might be able to join this trial: - Women who have never given birth before - Women carrying a single baby (not twins or more) - Women aged over 18 years old - Women who are between 35.0 and 36.6 weeks pregnant - Women who have provided written consent to take part Who may not be able to join: - Women whose baby h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04783597 · McGill University Health Centre/Research Institute of the McGill Unive... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇨🇦 CA

Who might be able to join this trial: - People who are pregnant with one baby (not twins or more) - People who have at least one high-risk factor, or at least two moderate-risk factors, for developing pre-eclampsia (a serious condition that can occur during pregnancy — the trial site can clarify which factors apply) W...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04832009 · University of Kansas Medical Center Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People with a BMI (body mass index) under 25, which is generally considered a healthy weight range - People whose body processes insulin normally, based on blood test results from fasting glucose and insulin levels - People aged between 18 and 79 years old - People with blood...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT04835857 · Dynocardia, Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - Healthy volunteers aged 18 or older, with equal numbers of males and females, who have a normal, regular heart rhythm. - People who are willing and able to commit to taking part in the study as described in the protocol. - People who are able to understand and sign a written cons...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04911491 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 50 years or older; women must be past menopause - People who have been diagnosed with moderate chronic kidney disease (stage 3 or 4), with kidney function that has been stable for the past 3 months - People who have high blood pressure that has not been fully con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05000515 · University of Colorado, Boulder Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇺🇸 US

**Who might be able to join this trial:** - Women who have been through menopause, with no menstrual period for more than 12 months - Women who have not used any hormone therapies in the past 12 months - Women aged 50 years or older - People who are able to give informed consent to participate - People who are willing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05009433 · Gdansk University of Physical Education and Sport Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2031
🇵🇱 PL

**Who might be able to join this trial:** *For pregnant women:* - The pregnancy is progressing in a way that allows participation in physical activity suited to pregnant women. - The person's obstetric care provider has given consent for them to take part in the study tests and exercise classes. - The person is willin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05106036 · University of Texas Southwestern Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have had at least one blood pressure reading showing a top number of 130 or higher, or a bottom number of 80 or higher, within the past 24 months - People who have had a visit with their primary care doctor within the last 24 months - People who can read and speak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05150197 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇺🇸 US

Who might be able to join this trial: - You or your child must be at least 4 years old - You or your child must have typical cognitive development (no developmental delays or syndromes) - You or your child must be able to wear virtual reality goggles comfortably for at least 10 minutes - A parent or guardian must be ab...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05166954 · Beijing Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People between 18 and 70 years old - People with a Body Mass Index (BMI) above 24 kg/m² (a measure of body weight relative to height) - People who are patients at Beijing Friendship Hospital scheduled for weight-loss (bariatric) surgery - People who have been diagnosed with h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05183763 · Tulane University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are fully insured by Blue Cross Blue Shield of Louisiana (BCBSLA) - People who have been continuously enrolled with BCBSLA for at least one year - People who plan to remain a BCBSLA member for the next year - People who speak English - People who have access to a t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05236348 · Aktiia SA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2025
🇨🇭 CH

Who might be able to join this trial: - Adults between 21 and 85 years old - People who can read and speak French - People who are able to do simple physical exercises - People who are available and willing to attend all 9 study visits - People who have signed the trial's consent form Who may not be able to join: - Cl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05242055 · Capital Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who are willing to sign a consent form agreeing to take part - People who are expected to develop chronic kidney disease (a long-term condition where the kidneys gradually lose their ability to function properly) Who may not be ab...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05287321 · Yoo-min Kim Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2025
🇰🇷 KR

**Who might be able to join this trial:** - Women who are pregnant with a single baby and are between 19 and 50 years old. - Women who have at least one of the following in their pregnancy history: a previous pregnancy complicated by preeclampsia (high blood pressure during pregnancy), a previous pregnancy where the ba...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05293756 · Case Western Reserve University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇸 US

**Who might be able to join this trial:** - You identify yourself as African American - You are 50 years of age or older - You have been diagnosed with high blood pressure, with a top number (systolic) reading of 130 or higher but below 170 - You have been prescribed at least two blood pressure medications, and at leas...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05297708 · Children's Hospital Medical Center, Cincinnati Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

**Who might be able to join this trial:** - Be between 6 and 18 years old - Have blood pressure that is elevated, but not quite at the highest stage of high blood pressure (called Stage 2 hypertension) — your doctor can check where your readings fall (confirm with trial site) - Be able to wear a blood pressure monitor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05309460 · Nebraska Methodist Health System Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 May 2024
🇺🇸 US

Who might be able to join this trial: - People who are admitted to hospital for a vaginal or cesarean birth at 24 weeks of pregnancy or later - People who have high blood pressure during their admission, meaning their top blood pressure number is 140 or higher, or their bottom number is 90 or higher, measured on two se...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05321368 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 October 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older at the time their information is reviewed - People who identify as non-Hispanic white, non-Hispanic Black/African American, and/or Hispanic - People who have been diagnosed with high blood pressure, and whose most recent clinic visit re...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05325437 · Northern Jiangsu People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2025
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with cirrhosis (scarring of the liver) from any cause, confirmed by a doctor's assessment, imaging, or tissue sample - People who have an enlarged spleen that is causing a reduction in blood cells (a condition where the spleen destroys blood cells t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05371977 · Helsinki University Central Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇫🇮 FI

**Who might be able to join this trial:** - People who have given their signed consent to take part in the study - People diagnosed with Normal Tension Glaucoma — a type of glaucoma where eye pressure has never been above 21 mmHg, the drainage angle in the eye is open, and there are specific signs of nerve damage visib...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05400824 · Institut National de la Santé Et de la Recherche Médicale, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇫🇷 FR

Who might be able to join this trial: - Adults between 18 and 67 years of age - People who have agreed to have their genetic information analysed as part of the study - People who have provided written consent to take part in the study Who may not be able to join: - People who are under judicial protection or legal gu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05421767 · National Taiwan University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2025
🇹🇼 TW

Who might be able to join this trial: - People who have high blood pressure, with a 24-hour blood pressure monitor reading above 130/80 mmHg - People aged between 20 and 80 years old - People whose kidneys are filtering at a sufficient level (a kidney function score above 45, as measured by a standard blood test) Who...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05434195 · University of Oxford Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇬🇧 GB

Who might be able to join this trial: **For people with preeclampsia:** - People diagnosed with preeclampsia before 34 weeks of pregnancy, within the last 48 hours, and with no birth planned within the next week - People receiving pregnancy care at the John Radcliffe Hospital - People aged 19 to 45 years - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05445544 · Zhujiang Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are currently pregnant - People who are carrying one baby (not twins or more) - People who are willing to attend regular pregnancy check-ups at one of the research centres - People who are willing to sign a written consent...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05453877 · Beijing Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 90 years old - People who are already part of the Kailuan Cohort study and have completed at least one visit where their medical history and physical measurements were recorded - People who are able to safely have CT and MRI scans (no medical reasons pr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05470439 · University of Arizona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who identify culturally as African-American or Latino - People who speak English or Spanish - People who have high blood pressure that is being managed with medication - People who take 5 or more medications on an ongoing basis - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05475015 · Shengjing Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 18 or older - People who are willing and able to provide written consent to participate - People who have been diagnosed with advanced chronic liver disease (long-term scarring of the liver), caused by any underlying condition - People for whom a liver pressure measur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05479461 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2025
🇺🇸 US

Who might be able to join this trial: - People between the ages of 30 and 90 years old - People who own a smartphone - People whose blood pressure reading taken in a clinic or doctor's office is 140 mmHg or higher (the top number) - People who are currently taking two or fewer blood pressure-lowering medications - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05500989 · Maastricht University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇳🇱 NL

**Who might be able to join this trial:** - Women aged 18 or older - (For the control group) Women who have a straightforward pregnancy at the time of joining, meaning no complications such as high blood pressure caused by pregnancy, preeclampsia, HELLP syndrome, or a baby that is smaller than expected for their stage...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05521776 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who are between 11 and 14 weeks pregnant - People who are 18 years of age or older - People who are covered by a health insurance system (including AME, a form of state medical aid) - People who have read and signed a consent form agreeing to take part **Who may not b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05522075 · The University of Texas at Arlington Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - Men and women between 50 and 64 years of age who either do not drink alcohol, drink at moderate levels, or occasionally binge drink. - Women who have gone through menopause, meaning their periods stopped at least one year ago. - People who can speak and understand English. Who m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05530512 · University of California, Irvine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇺🇸 US

Who might be able to join this trial: - You are between 45 and 75 years old - You have been diagnosed by a doctor with mild to moderate high blood pressure, whether or not you are currently taking medication for it, with blood pressure readings within a specific range (confirm with trial site for exact numbers) - Your...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05533645 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who have high blood pressure, chronic kidney disease at stage 4 or 5, or who have no known diseases - People aged 18 years or older - People who are attending nephrology or cardiology appointments, or who are recruited through a clinical investigation centre - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05545501 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People between the ages of 19 and 39. - People whose resting blood pressure is no higher than 150/90. - People with a Body Mass Index (BMI, a measure of body weight relative to height) below 35, or who are otherwise in good general health (confirm with trial site). - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05552547 · University Hospitals Cleveland Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

Who might be able to join this trial: - People who identify as African American, or whose parent identifies them as being of African American or partly African American ancestry Who may not be able to join: - People who have previously been diagnosed with high blood pressure - People who have been prescribed blood pre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05555095 · OSF Healthcare System Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇺🇸 US

Who might be able to join this trial: - People who receive care at one of four participating health care centers or OSF HealthCare, based on their insurance type - People whose health insurance is Medicaid, or who are covered by both Medicare and Medicaid - People who have been diagnosed with at least one of the follow...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05556902 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2029
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 89 years, of any gender - People who have been living with chronic pain for more than 3 months - People who are willing to visit a research lab in person - People who are willing to have a blood sample taken - People who are able to read and sign a consent form...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05563623 · Peking University People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People whose eye examination (a test called gonioscopy) shows that a specific part of the eye's drainage angle cannot be seen across 6 or more sections of the eye's full circle, in both eyes, with no scarring in the angle. - People who have normal eye pressure, a healthy opti...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05596773 · University Hospital, Basel, Switzerland Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
Lesotho🇨🇭 CH

**Who might be able to join this trial:** **At the village level:** - The village has between 40 and 100 households - The village chief has given their agreement for the village to take part - The village is able to identify or recruit a specially trained community health worker (called a CC-VHW) who meets all of the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05625724 · University Hospital, Toulouse Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 August 2028
🇫🇷 FR

**Who might be able to join this trial:** - You are a woman aged 18 or older who has never given birth before - You became pregnant through assisted reproduction techniques, such as IVF, ICSI, egg donation, or donor sperm insemination - You are carrying a single baby (not twins or more) - Your pregnancy is progressing...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05626426 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older - People who are able and willing to follow the study schedule and attend all required visits - People who have been clinically diagnosed with glaucoma, with visual field test results (Humphrey Visual Field 24-2) showing a mean deviation worse than -3...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05653973 · Anna Stanhewicz, PhD Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 31 March 2027
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who gave birth between 12 weeks and 5 years ago - People who had a normal pregnancy and did not take low-dose aspirin during that pregnancy - People who had a normal pregnancy and did take low-dose aspirin during that pregnancy - P...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT05655065 · University Hospital, Angers Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People who have dangerously low blood pressure that requires medication (called catecholamines) to keep it at a safe level - People who are receiving a specific blood pressure medication (norepinephrine) at a dose of 0.1 micrograms per kilogram per...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05662696 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇵🇰 PK

**Who might be able to join this trial:** - Pregnant women who are in their first or second trimester and are considered at high risk for a condition called preeclampsia (a serious blood pressure condition during pregnancy). High risk is defined using NICE guidelines, meaning the person has either one major risk facto...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05676476 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - The person enrolled must be pregnant at the time of joining the trial. - The pregnancy must be between 23 weeks and 0 days, and 35 weeks and 6 days along at the time of enrollment. - The pregnant person must have a high blood pressure condition related to pregnancy — either gesta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05676970 · Xavier University of Louisiana. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 55 years old - People who are able to speak English - People who are currently working in, or training for, industries such as healthcare, education, beauty, hospitality, food/culinary, or industrial plant work - People who are able to use telehealth technol...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05683093 · University of Oxford Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇬🇧 GB

**Who might be able to join this trial:** - You are willing and able to give your consent to take part in the study - You are male or female, aged between 30 and 40 years old at the time of joining - You previously took part in the ALSPAC study - You are able and willing to follow all the requirements of the study - Yo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05707442 · Beijing Tiantan Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2027
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with a condition called Idiopathic Intracranial Hypertension (IIH) — a condition involving raised pressure in the brain without a known cause — for more than 2 months, confirmed using standard diagnostic criteria - People whose spinal fluid pressure...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05765786 · Queen Mary University of London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 24 July 2027
🇬🇧 GB

Who might be able to join this trial: - People who are suspected of having a condition called primary aldosteronism (PA) but have not yet received a confirmed diagnosis, based on certain hormone and blood test results showing low renin levels, higher-than-normal sodium, or lower-than-normal potassium. - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05845905 · Yi Yang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

Who might be able to join this trial: - People aged 65 to 85 years old, of any gender. - People who have been diagnosed with essential (primary) hypertension and whose measured systolic blood pressure (the top number) is 140 mmHg or higher, whether or not they are currently taking blood pressure medication. - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05889650 · Brain Trauma Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 June 2028
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 65 years old - People with a low level of consciousness, as measured by a standard brain injury scale (Glasgow Coma Scale score of 3 to 8) - People whose pupils are equal in size and both react to light - People whose brain CT scan (on arrival or after surgery)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05924971 · MemorialCare Health System Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People diagnosed with a serious form of high blood pressure during pregnancy (called preeclampsia with severe features) that was identified during their delivery hospital stay. - People whose pregnancy care (both before and after birth) was provided by the Long Beach Memorial Ob/...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05934383 · Erasmus Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇳🇱 NL

**Who might be able to join this trial:** - People who are 18 years of age or older - People who received a kidney transplant at least 12 months ago and have been on a stable anti-rejection medication routine - People whose kidneys are filtering at a sufficient level (a blood test result called eGFR of 40 or above) (c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05955339 · Dartmouth-Hitchcock Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 April 2027
🇺🇸 US

**Who might be able to join this trial:** **For patients:** - People aged 65 years or older - People living with multiple health conditions — specifically, diabetes or high blood pressure, plus at least one other condition from this list: arthritis (osteoarthritis or rheumatoid arthritis), asthma, irregular heartbeat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05960604 · Recep Tayyip Erdogan University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
Turkey (Türkiye)

Who might be able to join this trial: - You are at least 18 years old - You are scheduled to have a major operation under general anaesthesia - Your surgery is expected to last longer than 2 hours - You are expected to stay in hospital for more than 2 days after your operation - You will have your blood pressure monito...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05979168 · Central Department of Public Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2026
Nepal

Who might be able to join this trial: - People who have been diagnosed with high blood pressure (hypertension) - People who have been taking or prescribed blood pressure-lowering medication for more than three months - People whose blood pressure is still not well controlled (above 130/80 mmHg) despite medication - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05999851 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇮🇹 IT

Who might be able to join this trial: - You are 18 years old or older - You are pregnant with one baby (not twins, triplets, etc.) - You have not had any previous pregnancies that lasted more than 12 weeks - You are willing and able to understand and sign a consent form to take part in the study Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06004674 · Endeavor Health Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People who had a previous single-baby pregnancy that ended in a serious complication — such as early birth before 37 weeks, a baby born smaller than expected (below the 10th percentile for weight), severe preeclampsia, or a pregnancy loss after 20 weeks — as confirmed by an...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06017362 · Barbara Burgos Blasco Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 8 February 2026
🇪🇸 ES

**Who might be able to join this trial:** - You are willing to give written consent and are able to attend all required study visits and follow the study procedures. - You are 18 years old or older at the time of your screening appointment. - You have high eye pressure or glaucoma that is currently being managed with e...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06033131 · Lina Bergman Phase 3 · 3 countries Recruiting
Recruiting Phase 3 Est. completion 31 December 2027
🇫🇮 FI🇳🇴 NO🇸🇪 SE

**Who might be able to join this trial:** - You have been diagnosed with preeclampsia (high blood pressure combined with protein in your urine) by your doctor - Your medical team has decided that it is appropriate to monitor and manage your condition without delivering the baby straight away (called "expectant managem...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06062394 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People registered with the Penn Medicine Primary Care Service Line - People whose last two blood pressure readings from a clinic visit in the past 12 months showed a systolic (top number) reading of 140 or higher - People who also meet at least one of the following condition...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06081010 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
Nepal

"Who might be able to join this trial: - People with high blood pressure readings of 140/90 mmHg or higher. Who may not be able to join: - People with a serious illness that requires them to stay in bed to recover. - People who are currently pregnant, due to their special health needs during pregnancy. Important: Alw...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06093932 · Xiyuan Hospital of China Academy of Chinese Medical Sciences Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2024
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 35 and 65 years old, of any gender - People diagnosed with mild (Grade 1) high blood pressure - People who are either not currently taking any blood pressure medication, or who have been taking it inconsistently in the past - People who are willing to sign...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06098300 · Medical University of Vienna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇦🇹 AT

**Who might be able to join this trial:** - You are a man or woman aged 18 or older - You are willing and able to sign a consent form agreeing to take part - Your eyes are healthy apart from any eye changes caused by high blood pressure - You are a non-smoker - You have been newly or previously diagnosed with mild to m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06111079 · FANG HE Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 December 2024
🇨🇳 CN

Who might be able to join this trial: - People who are less than 16 weeks pregnant and have had a normal nuchal translucency (NT) scan, which is a routine early pregnancy ultrasound - People who have at least one high-risk factor, or at least two moderate-risk factors, for pregnancy complications (confirm with trial si...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06122246 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - You have high blood pressure, meaning your resting blood pressure average is 135/85 mmHg or higher, measured across 3 readings in a row Who may not be able to join: - You are currently pregnant or planning to become pregnant within the next 6 months of joining the study - You ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06123377 · Saint Thomas Hospital, Panama Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 August 2026
Panama

Who might be able to join this trial: - Pregnant women who are between 24 and 40 weeks pregnant - People who have been diagnosed with gestational hypertension (high blood pressure that develops during pregnancy) according to standard medical guidelines - People whose blood test shows a specific protein ratio (called sF...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06132451 · Annina Vischer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇭 CH

**Who might be able to join this trial:** - People admitted to a general internal medicine hospital ward for a reason unrelated to heart or blood vessel problems — specifically, conditions that are not made worse by having uncontrolled high blood pressure. - People who have had raised blood pressure readings on at leas...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06152614 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2028
🇺🇸 US

**Who might be able to join this trial:** - People who speak and understand English fluently - People who live in Marion County - People between the ages of 35 and 75 - People who identify as non-Hispanic and Black, African-American, or biracial including African-American - People who had a blood pressure reading of 1...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06168461 · Anna Stanhewicz, PhD Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People who have had preeclampsia (a pregnancy complication involving high blood pressure) within the past 5 years - People who are 18 years of age or older Who may not be able to join: - People who currently take aspirin every day - People who have a skin disease or skin conditi...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06173947 · Nanfang Hospital, Southern Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇨🇳 CN

Who might be able to join this trial: - You are between 18 and 80 years old - You have a long-term (chronic) liver disease, whatever the cause - You have a sudden (acute) liver injury with significantly elevated bilirubin levels (a measure of liver function) in your blood (confirm with trial site) Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06181409 · McGill University Health Centre/Research Institute of the McGill Unive... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇨🇦 CA

Who might be able to join this trial: - People who are 18 years of age or older - People who have advanced chronic liver disease, determined by a liver stiffness measurement of 10 kPa or higher (a measure of liver scarring usually assessed by a scan) - People who are able to give informed consent to participate in the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06194591 · Menno Pruijm Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2028
🇨🇭 CH

**Who might be able to join this trial:** - People aged between 18 and 82 years old. - People who have been diagnosed with high blood pressure, with a systolic (top number) blood pressure reading of 135 mmHg or higher at home, at a clinic, or over a 24-hour monitor, and whose blood pressure medication has not changed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06216808 · DeepQure Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 March 2026
🇰🇷 KR

**Who might be able to join this trial:** - People aged between 19 and 79 years old (male or female) - People who have high blood pressure that has not been controlled despite taking at least 3 different types of blood pressure medications (including a water tablet/diuretic) on a stable dose for at least 4 weeks befor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06218355 · University of Texas Southwestern Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

Who might be able to join this trial: - Women who have recently given birth to a live baby at Parkland Hospital or Grady Health, and who receive their postpartum (after-birth) care at one of the designated community clinics connected to these hospitals. - Women who are 18 years of age or older and are able to provide i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06220721 · Medical College of Wisconsin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2029
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with a high blood pressure condition during pregnancy, specifically gestational hypertension, preeclampsia, eclampsia, or HELLP syndrome, based on standard medical guidelines - People who are within the first 4 days after giving birth (day 0 to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06229171 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇮🇹 IT

**Who might be able to join this trial:** - You must be an adult (over 18 years old) - You have been diagnosed with high blood pressure (also called essential hypertension) - You are taking at least one blood pressure medication that can be measured with a specific blood test available for this trial - You have a worki...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06239363 · Poznan University of Life Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 September 2027
🇵🇱 PL

Who might be able to join this trial: - Women between 18 and 45 years old - Women who are either healthy with no significant past medical history, or who have been diagnosed with preeclampsia (a pregnancy complication involving high blood pressure) - Women who are pregnant with one baby (not twins or more) - Women who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06246396 · University of Florida Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 July 2028
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older - People with hard-to-control treatment-resistant high blood pressure, meaning their blood pressure remains too high (average 24-hour reading of 125 mmHg or more systolic, or 80 mmHg or more diastolic) even while consistently taking 3 or more blood pre...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06249178 · Ohio State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are pregnant and aged 18 or older - People who enrolled at or before 16 weeks and 6 days of pregnancy, based on their estimated due date calculated using standard obstetric guidelines - People carrying a single live baby in the uterus - People who have at least on...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06258473 · BRAC University Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 September 2026
Bangladesh

Who might be able to join this trial: - People aged 40 years or older - People who have both high blood pressure and diabetes - People who live in the specific areas where the study is taking place - People who are willing to take part in the study Who may not be able to join: - People who are under 40 years of age -...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06266260 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2025
🇮🇹 IT

Who might be able to join this trial: - You have been newly diagnosed with swollen veins in your esophagus or stomach (called varices), or there are signs suggesting high blood pressure in the vein that supplies your liver (confirmed by scans, blood tests, or other non-invasive tests) - You have not previously taken a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06281665 · Malamo Countouris Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - People who are 18 years old or older and have recently given birth - People who have been diagnosed with preeclampsia (a pregnancy complication involving high blood pressure) Who may not be able to join: - People whose baby was diagnosed with a physical abnormality before birth...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06288204 · Universidade Federal Fluminense Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇧🇷 BR

**Who might be able to join this trial:** - People who have been diagnosed with stage 3 or stage 5 chronic kidney disease (meaning their kidneys are working at a reduced level, with a specific kidney function score between 15 and 59) - People who have been receiving nutrition treatment as an outpatient for at least 6 m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06291207 · Addpharma Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 July 2025
🇰🇷 KR

Who might be able to join this trial: - People who have given their written agreement to participate in the trial - People who have been diagnosed with essential hypertension (high blood pressure that does not have a known underlying cause) - Additional inclusion criteria may apply (confirm with trial site) Who may no...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06307574 · University of Arizona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇺🇸 US

Who might be able to join this trial: - People who are 60 years of age or older - People who live independently in the community (not in a care facility) - People who speak and understand English fluently - People who have adequate vision and hearing ability (as reported by themselves) - People who feel they have some...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06317467 · IRCCS Burlo Garofolo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇮🇹 IT

Who might be able to join this trial: - Women who have a normal, healthy pregnancy and agree to sign a consent form and return to the maternity hospital for a follow-up visit 40 days after giving birth. - Women who have been diagnosed with pre-eclampsia, a condition where high blood pressure develops after 20 weeks of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06319014 · East Carolina University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇺🇸 US

Who might be able to join this trial: - Women who are healthy and between 18 and 40 years old - Women who are less than 16 weeks pregnant with a single baby (not twins or more) - Women with a body mass index (a measure of body weight relative to height) between 18.5 and 45.0 - Women who are not currently doing regular...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06335433 · Swansea University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇬🇧 GB

**Who might be able to join this trial:** - People between 18 and 65 years of age - People who report low or moderate levels of physical activity, as measured by a standard physical activity questionnaire (IPAQ) - People who have previously been diagnosed with high blood pressure, or whose resting blood pressure readin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06339879 · Purdue University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - Men and women between 21 and 60 years old - People whose HbA1c (a blood sugar measurement) is between 5.7% and 6.4%, which generally indicates blood sugar levels in the prediabetes range - People who prefer not to take medications, but those on medication may still be conside...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06340152 · University of California, San Diego Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇺🇸 US

Who might be able to join this trial: - Pregnant women between 18 and 50 years of age - Between 10 and 24 weeks pregnant at the time of joining the trial - Carrying a single baby (not twins or more) - Planning to give birth at one of the two study hospitals (UC San Diego or Vanderbilt University Medical Center) Who ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06363305 · Skidmore College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 and over who are generally healthy apart from having elevated blood pressure - Both men and women from the local community may be eligible - Non-smokers only **Who may not be able to join:** - Women who have stopped having periods for a reason other than birth...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06391073 · Northwestern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older - People who had at least one blood pressure reading in the emergency department (ED) with the top number at 160 or higher, or the bottom number at 100 or higher - People whose blood pressure, when checked again after that first high reading, still showed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06394934 · Korea University Anam Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇰🇷 KR

Who might be able to join this trial: - Adults who are 19 years of age or older. - People who have been diagnosed with high blood pressure (hypertension). - People who have been regularly taking medication to manage their blood pressure for at least two years. - People who have access to a blood pressure monitor that c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06416761 · Ospedale San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 May 2040
🇮🇹 IT

Who might be able to join this trial: - People who have a specific type of kidney disease (the exact type will depend on the sub-protocol relevant to their condition — confirm with trial site) Who may not be able to join: - Certain exclusion criteria apply, but these are specific to each sub-protocol within the trial...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06424756 · University of Georgia Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 March 2030
🇺🇸 US

**Who might be able to join this trial:** - People who identify as either non-Hispanic Black or non-Hispanic White - Men and women between 18 and 75 years old - People whose blood pressure is in the normal range (top number below 130 and bottom number below 85) - People with a low-density lipoprotein ("bad") cholestero...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06427408 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2028
🇫🇷 FR

Who might be able to join this trial: - People aged between 18 and 50 years old - People who are pregnant with a single baby and are between 11 and 15 weeks into their pregnancy - People who have been recommended by their doctor to have a chorionic villus biopsy (a procedure to test the baby's genetic material) and hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06441630 · Addpharma Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 September 2025
🇰🇷 KR

Who might be able to join this trial: - People who have given their signed agreement to take part in the trial - People who have been diagnosed with essential hypertension (high blood pressure that has no identified underlying cause) - Additional inclusion criteria may apply (confirm with trial site) Who may not be ab...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06444308 · University of Wisconsin, Madison Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
Guatemala

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with high blood pressure, with a reading of 140/90 or higher, or who are currently taking medication to manage blood pressure. - People who are able to understand and agree to participate in the study on their own behalf. Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06447740 · Peking University First Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 3 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have been diagnosed with high blood pressure that is not well controlled (with specific blood pressure readings measured over the day using a monitoring device), even while taking 2 or more types of blood pressure medications - People who have a narrowing in the ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06450327 · University of Campinas, Brazil Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇧🇷 BR

**Who might be able to join this trial:** - Men and women over 35 years of age who have been diagnosed with resistant high blood pressure (blood pressure that remains high despite treatment), as defined by current medical guidelines - People who are able to understand, speak, and answer questions during the study - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06464159 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇫🇷 FR

Who might be able to join this trial: - People aged between 18 and 50 years old - People who are pregnant with a single baby (not twins or more) between 20 and 41 weeks of pregnancy - People who either have preeclampsia or have a normal pregnancy Who may not be able to join: - People who are under 18 years old - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06468202 · Ohio State University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2029
🇺🇸 US

**Who might be able to join this trial:** - You are pregnant with a single living baby (or twins) at 16 weeks and 6 days of pregnancy or earlier - You are 14 years old or older and able to give your own consent to participate - You have at least one higher-risk factor for high blood pressure in pregnancy, such as: a p...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06500403 · Nanfang Hospital, Southern Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇳 CN

Who might be able to join this trial: - You have received a type of cancer treatment called platinum-based chemotherapy for a solid organ tumor - You are between 18 and 80 years old - You are willing and able to sign a consent form agreeing to take part in the study Who may not be able to join: - Your liver scans or t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06507657 · University of Minnesota Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 15 January 2029
🇺🇸 US

**Who might be able to join this trial:** - People who are over 60 years of age - People who have been diagnosed with high blood pressure - People with a body mass index (BMI) of 30 or higher (a measure of body weight relative to height) - People who have had a heart ultrasound (echocardiogram) done within 60 days befo...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06511479 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2027
🇺🇸 US

Who might be able to join this trial: - People who are female and already enrolled in the Jackson Heart Study - People who are willing to be randomly assigned to a study group and follow all parts of the study plan - People who are willing to have their group sessions audio-recorded Who may not be able to join: - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06513975 · Sky Labs Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 August 2025
🇰🇷 KR

Who might be able to join this trial: - People who are aged 18 years or older but younger than 80 years - People who are willing to voluntarily take part and sign a written consent form - People who are willing to follow the trial's procedures and schedule Who may not be able to join: - People who do not give their co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06515795 · Universidade do Porto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2024
🇵🇹 PT

**Who might be able to join this trial:** - You are between 40 and 75 years old - You have previously been diagnosed with high blood pressure that has been difficult to control with medication (known as "resistant hypertension") - You have been on a stable medication routine for this condition for at least 6 months **...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06523465 · Third Military Medical University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been clinically diagnosed with primary aldosteronism (a condition where one or both adrenal glands produce too much of a hormone called aldosterone, often causing high blood pressure) **Who may not be able to join:** - People who have a known allergy to any o...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06527794 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
🇺🇸 US

**Who might be able to join this trial:** - People who identify as Black or African American - People who have been diagnosed with high blood pressure (hypertension) - People aged between 21 and 85 years old - People whose blood pressure is not well controlled, meaning one of the following applies: their two most recen...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06538454 · University of Sao Paulo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2024
🇧🇷 BR

**Who might be able to join this trial:** - Women between the ages of 50 and 65 years old - Women who have been through menopause, meaning their periods have stopped for 12 months or more - Women who have already been diagnosed with high blood pressure and are currently taking medication to treat it - Women who are not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06545981 · Medical University of Vienna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 May 2026
🇦🇹 AT

**Who might be able to join this trial:** **For people with idiopathic intracranial hypertension (a condition where pressure inside the skull is too high for no clear reason):** - Adults aged 18 or older - People who have recently been diagnosed with idiopathic intracranial hypertension for the first time, or whose co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06555900 · University Hospital, Brest Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇫🇷 FR

Who might be able to join this trial: - You are older than 18 years of age - You have been admitted to an intensive care unit for less than 3 days due to a brain or nervous system injury - You have a sensor in place to monitor the pressure inside your skull Who may not be able to join: - You are under a form of legal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06555952 · Clinical Nutrition Research Center, Illinois Institute of Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 July 2026
🇺🇸 US

Who might be able to join this trial: - People between 40 and 60 years of age - People with a body mass index (a measure of body weight relative to height) below 30 - People with a systolic blood pressure (the top number) between 120 and 140, and a diastolic blood pressure (the bottom number) below 90, measured at the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06557005 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 May 2027
🇺🇸 US

**Who might be able to join this trial:** - You are receiving pregnancy care at a Massachusetts General Hospital (MGH)-connected obstetrics practice (note: people attending the MGH HOPE Clinic are not eligible, as that clinic has a separate care model) - You are currently pregnant (with a living baby at 24 weeks or mo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06558877 · Xijing Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 80 years old - People who have high blood pressure (measured on three separate days, with a top number of 140 or higher, or a bottom number of 90 or higher), who are already taking blood pressure medication but whose blood pressure is still not wel...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06559891 · SoniVie Inc. Not Applicable · 5 countries Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇫🇷 FR🇩🇪 DE🇬🇷 GR🇮🇹 IT🇺🇸 US

**Who might be able to join this trial:** - People who have signed and dated a consent form agreeing to take part - Adults aged between 22 and 75 years old at the time of signing consent - People who have a documented diagnosis of high blood pressure (hypertension) - People who have previously been prescribed, or are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06591117 · Ocumedex Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
El Salvador

**Who might be able to join this trial:** - People aged between 22 and 85 years old - People who have been diagnosed with glaucoma that has not been controlled by the maximum amount of eye drop or medication treatment that can be tolerated - People whose glaucoma did not improve after one or more eye operations (such...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06593496 · Wayne State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - You are a patient seen at a Mobile Health Unit with blood pressure that is higher than normal (top number of 120 or more, and/or bottom number of 80 or more) - You have a phone that can receive text messages - You are 18 years of age or older - You agree to allow the research tea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06595251 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 17 May 2027
🇺🇸 US

Who might be able to join this trial: - People who are already enrolled in the Miami-Dade Fit2Play study may be included in this analysis. Who may not be able to join: - People who are not enrolled in the Miami-Dade Fit2Play study would not be included in this analysis. Important: Always verify eligibility with the t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06605807 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 October 2026
🇺🇸 US

**Who might be able to join this trial:** **For clinicians (doctors and advanced practice providers):** - Attending clinicians who work on the general medicine or hospital medicine service at one of these hospitals: UPMC Presbyterian, UPMC Montefiore, UPMC Shadyside, UPMC Mercy, or UPMC Magee-Women's Hospital - Clinic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06607705 · Fundacio Privada Mon Clinic Barcelona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇪🇸 ES

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with primary open-angle glaucoma (a common type of glaucoma) and whose eye pressure was recorded as higher than 21 mm Hg before treatment started, as shown in their medical records. - Adults aged 18 or older diagnosed with a type of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06629649 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 September 2029
🇺🇸 US

Who might be able to join this trial: - You are African American or Hispanic and are 40 years old or older - You are non-Hispanic white and are 50 years old or older - You are 18 years old or older and have been diagnosed with type 1 or type 2 diabetes - You are 18 years old or older and have already been diagnosed wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06632379 · Ohio State University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 15 September 2026
🇺🇸 US

Who might be able to join this trial: - People who have recently given birth - People who are 20 years of age or older and able to give informed consent - People who were diagnosed with high blood pressure during pregnancy (gestational hypertension) or a serious pregnancy complication involving high blood pressure and...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06634069 · University Hospital Pilsen Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 October 2027
🇨🇿 CZ

**Who might be able to join this trial:** - People aged between 18 and 90 years old - People diagnosed with septic shock, meaning they have a serious infection that has caused a significant decline in organ function, require medication to keep their blood pressure stable, and have had an elevated blood lactate level (...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06643130 · JW Pharmaceutical Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 April 2026
🇰🇷 KR

"Who might be able to join this trial: - People who have both high blood pressure and high cholesterol (a condition called dyslipidemia) Who may not be able to join: - People whose blood pressure and LDL cholesterol (sometimes called "bad" cholesterol) readings do not fall within the specific levels required by the tr...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06643741 · Sequenom, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - The person enrolling must be female and at least 18 years old - The person must be willing to sign and date a consent form before joining - The person must be pregnant with a single baby (not twins or more) and between 11 and 14 weeks along in the pregnancy - The person must agre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06643819 · Chong Kun Dang Pharmaceutical Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 March 2026
🇰🇷 KR

**Who might be able to join this trial:** - People who are 19 years old or older. - People who have chosen to take part willingly and have signed a consent form. **Who may not be able to join:** - People who have, or are suspected to have, high blood pressure caused by another underlying medical condition (called seco...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06646198 · Fei Gao Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 May 2026
🇨🇳 CN

Who might be able to join this trial: - People who have voluntarily agreed to take part and have signed a consent form - People aged 18 to 75 years old, of any gender - People who have been confirmed by pathology (laboratory testing of tissue) to have hepatocellular carcinoma (a type of liver cancer), with at least one...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06651879 · Ain Shams University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 November 2025
🇪🇬 EG

**Who might be able to join this trial:** - People aged between 18 and 60 years old - People who are critically ill with preeclampsia and are having a caesarean section under general anaesthesia - People carrying one baby or multiple babies - People who are mentally competent and able to make their own decisions - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06666361 · Chimei Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇹🇼 TW

**Who might be able to join this trial:** - You have been diagnosed with high blood pressure for at least one year, and your blood pressure is not fully controlled even while taking medication (with readings at or above 130/80 mmHg). - You are 45 years of age or older, have been told by a doctor that you have high bloo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06669806 · C. R. Bard Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 18 to 75 years old - People diagnosed with high blood pressure in the liver's main vein (portal hypertension) caused by liver scarring (cirrhosis), and who have had bleeding from swollen veins in the digestive tract, fluid around the lungs caused by liver disease, or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06676553 · National Taiwan University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 October 2026
🇹🇼 TW

Who might be able to join this trial: - People who have high blood pressure (hypertension) and are willing to undergo a procedure called renal denervation, which targets the nerves around the kidneys to help lower blood pressure. - People who are either taking medication to manage their blood pressure, or whose blood p...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06680986 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2022
🇫🇷 FR

Who might be able to join this trial: - People who had a full blood pressure assessment done while they were admitted to the Cardiology department at either Croix Rousse Hospital or Lyon Sud Hospital at some point between January 2018 and December 2021. Who may not be able to join: - People who were under 18 years old...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06688409 · Centre Integre Universitaire de Sante et Services Sociaux du Nord de l... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2027
🇨🇦 CA

Who might be able to join this trial: - Adults aged 18 or older who are already scheduled to have a 24-hour blood pressure monitoring test (where a device records blood pressure at regular intervals throughout the day and night) Who may not be able to join: - People whose upper arm measures less than 22 cm or more tha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06693934 · Juliana CN Chan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
Hong Kong

Who might be able to join this trial: - People who are between 18 and 44 years old - People who have at least one known risk factor for diabetes, which may include: carrying excess weight around the abdomen or generally, a family history of diabetes, a history of smoking, a history of high blood pressure, high blood su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06698536 · Aktiia SA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇭 CH

**Who might be able to join this trial:** - People between 21 and 85 years old - People (or their witnesses) who can read and speak French fluently - People who are willing to attend the study visit and follow the study procedures - People who have signed the consent form agreeing to take part **Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06700044 · Region Skane Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇸🇪 SE

**Who might be able to join this trial:** - Pregnant women aged 18 or older - Women considered at high risk of preeclampsia (a serious condition involving high blood pressure during pregnancy), meaning they have at least one high-risk factor, or three or more moderate-risk factors, according to Swedish obstetric guidel...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06722625 · Poznan University of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇵🇱 PL

Who might be able to join this trial: - You are willing to voluntarily sign a consent form to take part in the study. - You are between 18 and 80 years old. - You have been diagnosed with high blood pressure (either newly diagnosed or already receiving treatment), based on Polish Society of Hypertension guidelines from...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06730230 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇺🇸 US

Who might be able to join this trial: - People who identify as Latinx - People who are fluent in English or Spanish - People who are 18 years of age or older - People who receive care at one of the 10 participating safety-net primary care clinics - People whose medical records show high blood pressure readings (average...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06740838 · Medical University of Gdansk Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇵🇱 PL

Who might be able to join this trial: - People who are suspected of having, or have been diagnosed with, high blood pressure (hypertension) - People between the ages of 40 and 75 - People who have had aldosterone and renin blood test results available during a one-day clinic visit (these are hormones that affect blood...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06769269 · Moroccan Society of Cardiology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 January 2026
Morocco

Who might be able to join this trial: - People who are 18 years of age or older - People whose blood pressure has been measured at 140/90 mmHg or higher in a clinic or hospital setting, OR higher than 135/85 mmHg when measured at home or with a portable blood pressure monitor worn over time - People who have agreed to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06778239 · National Human Genome Research Institute (NHGRI) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 December 2034
🇺🇸 US

**Who might be able to join this trial:** *If you have high blood pressure (affected individuals):* - Children aged 2–12 years who have a blood pressure reading above a certain level for their age (above the 95th percentile or 120/80 mmHg), confirmed by medical records, and who are willing to give biological samples,...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06785116 · University of Michigan Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 August 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are admitted for delivery, or enrolled in a postpartum blood pressure monitoring program following delivery, at the University of Michigan Labor and Delivery unit - People who are at least 23 weeks pregnant at the time of delivery (single or multiple babies, with...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06797908 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇮🇹 IT

Who might be able to join this trial: - People under 18 years of age who have been diagnosed with high blood pressure or blood pressure levels that are on the higher end of the normal range Who may not be able to join: - People whose blood pressure readings are fully within the normal range Important: Always verify e...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06804161 · Prof. Dr. med. Ingo Eitel Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 May 2032
🇩🇪 DE

**Who might be able to join this trial:** - People aged 60 years or older - People with high blood pressure — either newly diagnosed (confirmed by two separate measurements on different days showing systolic pressure above 140 mmHg or diastolic pressure above 90 mmHg), or previously diagnosed (confirmed by one measurem...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06814509 · University of Arkansas Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2029
🇺🇸 US

**Who might be able to join this trial:** - People who are between 16 and 44 years old - People who are pregnant and no more than 18 weeks along - People who speak English, Spanish, or Marshallese - People who have a valid email address **Who may not be able to join:** - No specific exclusion criteria were listed for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06822439 · Beth Israel Deaconess Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - You are pregnant with a baby growing in the womb, and you are more than 32 weeks along in your pregnancy - Your obstetrician (pregnancy doctor) has recommended that you have fetal (baby) monitoring or testing at least once a week - You are able to speak and understand English Wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06823947 · Kyowa Kirin Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2027
🇯🇵 JP

Who might be able to join this trial: - You must be willing to take part and give your written agreement to join the study. - For Part 1 (healthy volunteers): You must be a Japanese healthy adult aged 18 to under 55, or a non-Asian healthy man aged 18 to under 55; Japanese healthy adults aged 65 to under 80 may also be...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06826755 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 40 and 55 years old - You are female, have a uterus, and have at least one ovary - You have been diagnosed with high blood pressure, take medication for high blood pressure, or have had a blood pressure reading of 130/80 mmHg or higher at a doctor's office - I...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06826859 · Thomas Jefferson University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2029
🇺🇸 US

Who might be able to join this trial: - People who are pregnant with a single baby and are less than 16 weeks along, with the pregnancy dates confirmed by ultrasound - People who have at least one high-risk factor for preeclampsia (a serious condition involving high blood pressure in pregnancy), or at least two moderat...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06828692 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 35 and 79 years old - People who regularly attend a clinic for high blood pressure treatment and do not plan to travel during the study period - People who have been diagnosed with high blood pressure, with a systolic (top number) blood pressure reading of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06841575 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

**Who might be able to join this trial:** **Group 1 – Healthy Adults:** - You are 18 years of age or older - You are generally healthy with no known eye problems other than needing glasses or contacts - You are willing and able to agree to take part in the study **Group 2 – Adult Eye Clinic Patients:** - You are 18 y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06842875 · Women and Infants Hospital of Rhode Island Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2029
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older and have recently given birth at a birthing hospital in Rhode Island - People who were diagnosed with a high blood pressure condition related to pregnancy, either during pregnancy or after delivery - People who speak English, Spanish, Portu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06843577 · Zona Health, Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 22 or older, of any gender - People who have been diagnosed with elevated blood pressure or high blood pressure, confirmed by a seated arm cuff measurement at the first visit - People who have not taken any blood pressure-lowering medications for at least 30 days...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06844019 · Herlev Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 January 2027
🇩🇰 DK

Who might be able to join this trial: - People who are 18 years of age or older - People who are pregnant with a single baby (not twins or more) - People who plan to breastfeed their baby - People who can read and understand Danish Who may not be able to join: - People who are pregnant with twins or more - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06845514 · Université de Sherbrooke Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2028
🇨🇦 CA

Who might be able to join this trial: - People aged between 50 and 70 years old - People who have not had a menstrual period for 12 months in a row (indicating they have gone through menopause) - People with blood pressure readings in the normal-high range or classified as stage 1 high blood pressure (confirm with tria...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06845579 · Heart Center Leipzig - University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇩🇪 DE

Who might be able to join this trial: - People with confirmed high blood pressure, where the reading is above 140/90 mmHg when measured in a standardised clinic setting - People who are currently taking between 3 and 5 different types of blood pressure medication - People who are over 18 years of age - People who are w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06855342 · King's College Hospital NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇬🇧 GB

**Who might be able to join this trial:** *For healthy volunteers (control group):* - People aged 18 or older - People attending a routine eye clinic appointment with dilating eye drops for an OCT scan, who are presumed to have normal pressure in the brain *For patients scheduled for a lumbar puncture or brain pressu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06855407 · Umeå University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 December 2026
🇸🇪 SE

Who might be able to join this trial: - People classified as generally healthy to having some controlled medical conditions (known as ASA classification 1–3, confirm with trial site) - People with a body weight in the normal to healthy range, based on a body mass index (BMI) between 18.5 and 29.9 - People who score abo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06858345 · Fundacion para la Formacion e Investigacion Sanitarias de la Region de... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 January 2026
🇪🇸 ES

Who might be able to join this trial: - People who are 18 years of age or older - Women who are pregnant with one baby or twins, and whose pregnancy has been complicated by a high blood pressure condition related to pregnancy Who may not be able to join: - People under 18 years of age - Women who have a diagnosed ment...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06859177 · Maxima Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇳🇱 NL

**Who might be able to join this trial:** - People who are at least 18 years old - Pregnant people who are between 32 weeks and 0 days, and 36 weeks and 6 days along in their pregnancy - People who are carrying a single baby (not twins or more) - People who have a medical reason to have their baby monitored at least t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06859359 · Washington University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
Nigeria

Who might be able to join this trial: - Adults over 18 years old who have recently given birth - Emancipated minors who have recently given birth (in line with Nigerian guidelines for young people's participation in research and reproductive health services — confirm with trial site for details) - People who were diagn...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06861075 · University Hospital, Clermont-Ferrand Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People who have cirrhosis (scarring of the liver from any cause) with signs suggesting high blood pressure in the portal vein (the large vein supplying the liver), based on specific liver stiffness measurements and/or low platelet counts in the bloo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06861309 · Carilion Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 45 years at the time of screening - People carrying a single baby (not twins or more) with no known physical abnormalities or suspected genetic conditions - People whose pregnancy does not show signs of the baby growing too slowly (for the Normal Fetal Weight ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06863012 · Fundacio Privada Mon Clinic Barcelona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇪🇸 ES

**Who might be able to join this trial:** - You are between 18 and 85 years old (inclusive) at the time of signing the consent form. - You have a history of liver disease and high blood pressure in the liver's blood vessels, or suspected liver scarring (cirrhosis), and need a specific pressure measurement procedure cal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06877221 · Shenzhen Pulsecare Medical Technology Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 70 years old (based on the date standardised medication begins). - People whose clinic systolic blood pressure remains at or above 140 mmHg and at or below 180 mmHg after taking at least two different blood pressure-lowering medications for 4 weeks...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06877234 · Shenzhen Pulsecare Medical Technology Co., Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 to 65 years old - People diagnosed with essential hypertension (high blood pressure that is not caused by another medical condition) - People who have been consistently taking 2 or more blood pressure medications at standard doses for at least 4 weeks before j...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06881082 · Tanta University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇪🇬 EG

Who might be able to join this trial: - Adults aged over 18 years - People who have been diagnosed with cirrhosis (scarring of the liver) - People who have had an endoscopy (a camera procedure to look inside the digestive tract) showing medium or large swollen veins in the food pipe (esophageal varices) Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06885073 · Compremium AG Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇺🇸 US

Who might be able to join this trial: - People who have signed and dated a consent form agreeing to take part - Both males and females are eligible - People from birth up to 21 years of age - People who already have a central line (a tube placed into a large vein) for monitoring blood pressure in a vein as part of thei...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06886087 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 February 2027
🇺🇸 US

Who might be able to join this trial: - People who are living kidney donors (meaning they are donating a kidney to another person while still alive) Who may not be able to join: - People who do not meet Mayo Clinic Rochester's medical standards for living kidney donation surgery (confirm with trial site) - People whos...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06891911 · Beth Israel Deaconess Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People whose resting blood pressure readings fall within a specific range: systolic (top number) between 120 and below 160, and diastolic (bottom number) below 110 - People who currently live in Florida, Georgia, or Tennessee - People who are able to receive home-delivered grocer...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06900101 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇫🇷 FR

Who might be able to join this trial: - People who are admitted to the neurological critical care unit at Wertheimer Hospital in Bron - People whose brain and nervous system activity is being monitored using the CNS MOBERG® monitoring system during their hospital stay Who may not be able to join: - People who do not w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06913712 · University of Valencia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2028
🇪🇸 ES

Who might be able to join this trial: - Adults aged 18 or older, with no upper age limit, at the time of joining the trial. - People who have been diagnosed with Idiopathic Intracranial Hypertension (a condition where pressure inside the skull is higher than normal for no known reason), confirmed using a specific set o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06917131 · Universidade Federal Fluminense Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 December 2026
🇧🇷 BR

Who might be able to join this trial: - People who have been diagnosed with stage 1 high blood pressure (the early, milder stage of high blood pressure) - People who have been receiving regular treatment for their high blood pressure for more than 6 months - People whose blood pressure medication doses have not changed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06918236 · Aristotle University Of Thessaloniki Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇧🇬 BG🇬🇷 GR🇪🇸 ES

**Who might be able to join this trial:** - People who are pregnant with one baby or more than one baby - People whose pregnancy is between 11 weeks and 0 days and 13 weeks and 6 days along, with a baby that has a heartbeat **Who may not be able to join:** - People whose baby has been found to have a known genetic con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06928727 · Centre Hospitalier Universitaire, Amiens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇫🇷 FR

Who might be able to join this trial: - People who have been diagnosed with craniostenosis (a condition where the bones in a baby's skull join together too early) Who may not be able to join: - People who have posterior plagiocephaly (a condition where the back of the head becomes flattened, typically from external pr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06933836 · Barnet Dulaney Perkins Eye Centers Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2027
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with a type of glaucoma called primary open angle glaucoma (POAG) - You are 30 years of age or older - Your eye pressure (the fluid pressure inside your eye) is between 18 and 26 mmHg - Your glaucoma is considered mild or moderate (not advanced) - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06935513 · Affiliated Hospital of Nantong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 October 2025
🇨🇳 CN

Who might be able to join this trial: - You have been diagnosed with high blood pressure (hypertension) - You have been diagnosed with diabetes - You have been diagnosed with atrial fibrillation (an irregular heartbeat condition) - You are a smoker - You are not physically active on a regular basis - You are considered...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06937164 · Canterbury Christ Church University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2025
🇬🇧 GB

Who might be able to join this trial: - Adults aged 18 years or older - People who consider themselves physically inactive or not active enough to meet current physical activity guidelines - People who are not currently doing any structured resistance or isometric (muscle-tensing) exercise training - People who are abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06938516 · A.Menarini Asia-Pacific Holdings Pte Ltd Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 30 November 2028
🇮🇩 ID🇲🇾 MY🇵🇭 PH🇰🇷 KR🇹🇼 TW🇹🇭 TH🇻🇳 VN

**Who might be able to join this trial:** - Adults aged 18 or older who have either newly diagnosed or uncontrolled high blood pressure (with specific blood pressure readings recorded at a screening appointment), as defined by 2018 European heart guidelines. - People with high blood pressure — with or without other he...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06940011 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2027
🇳🇱 NL

**Who might be able to join this trial:** - People who have high blood pressure that is not controlled (office reading of 140/90 mmHg or higher) despite taking three or more blood pressure medications from different drug groups, including a water tablet (diuretic), each at the highest dose the person can tolerate as j...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06941116 · Qifu Li Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People between 18 and 75 years of age (any sex) - People who have been diagnosed with high blood pressure, meaning their blood pressure readings were 140/90 mmHg or higher on at least two separate occasions - People who have been taking at least one blood pressure medication...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06948838 · Boston Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇺🇸 US

Who might be able to join this trial: - Adults over 18 years old who receive their regular (primary) healthcare at one of the 9 participating clinics and have had a visit with their regular doctor in the past year - People who have been identified as having high blood pressure, based on at least one of the following: h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06952348 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇸🇪 SE

**Who might be able to join this trial:** - Men and women aged 35 or older who have been diagnosed with high blood pressure (with or without medication for it), as recorded in their medical records - People with a body mass index (BMI) between 27 and 40, meaning they are in the overweight or obese range - People whose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06953115 · Fundación Internacional René Mey Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇲🇽 MX

Who might be able to join this trial: - Women over 18 years old who are pregnant and have been diagnosed with mild preeclampsia (a pregnancy condition involving high blood pressure). - People attending their first appointment at the obstetrics outpatient clinic at a Regional General Hospital of IMSS Jalisco. - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06962488 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2030
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 55 years at the time of screening. - People who have been diagnosed with high blood pressure, shown by a resting blood pressure reading of 130–160 (top number) or 80–100 (bottom number) measured in a clinic, or who are currently taking medication for high b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06966713 · University of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 13 July 2026
🇺🇸 US

**Who might be able to join this trial:** - You are over 18 years old - You have a severe traumatic brain injury (TBI), confirmed by a standard brain function scoring test (called the Glasgow Coma Scale) showing a very low score, measured after emergency stabilization and without the effects of sedation or muscle-relax...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06970509 · Shanghai Zhongshan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with portal hypertension (high blood pressure in the vein that supplies blood to the liver) - People who had imaging scans and a camera examination of the digestive tract (endoscopy) within one week of being admitted to hospital - People whose endos...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06980961 · Science Valley Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇧🇷 BR

**Who might be able to join this trial:** - Women and men between 18 and 89 years old who have a skin condition called stasis dermatitis, caused by high blood pressure in the veins (venous hypertension) - People who agree to the terms of the study and sign a consent form - People who are able to attend all required app...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06984211 · HJN Sverige AB/Neko Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇸🇪 SE

Who might be able to join this trial: - Adults who are already receiving regular care at one of the participating trial sites, or who have been specifically invited to take part. - People who have read the study information and signed a consent form agreeing to participate. Who may not be able to join: - People who ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06988501 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 20 and 70 years old - People who have been diagnosed with high blood pressure, or who have elevated blood pressure readings (top number between 120–139 and/or bottom number between 80–89) - People whose current diet is considered unhealthy, based on a stan...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07013929 · Medtronic Vascular Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇬🇷 GR🇮🇪 IE

**Who might be able to join this trial:** - People aged between 20 and 70 years old - People whose blood pressure, measured at a clinic, shows a top number (systolic) of 150 or higher but below 180, and a bottom number (diastolic) of 90 or higher - People who are currently prescribed one, two, or three different types...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07019246 · Tongji Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2026
🇨🇳 CN

**Who might be able to join this trial:** - People rated as ASA Class I, II, or III — a standard medical fitness scale used by anaesthetists to assess overall health before surgery (confirm with trial site) - People with a body mass index (BMI) between 18 and 28 kg/m² - People scheduled for a planned (non-emergency) a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07027254 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇰🇷 KR

**Who might be able to join this trial:** - You are 19 years old or older - You have been diagnosed with a condition called primary aldosteronism (PA), based on specific medical guidelines from 2016 - You have already had a CT scan of your adrenal glands - You are willing and able to sign a consent form agreeing to tak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07031739 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇺🇸 US

Who might be able to join this trial: - People who speak English or Spanish - People who have been diagnosed with high blood pressure - People who have been prescribed at least one medication to lower blood pressure (such as a water pill, calcium channel blocker, beta-blocker, ACE inhibitor, or ARB) - People whose last...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07042386 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2028
🇺🇸 US

Who might be able to join this trial: - Women who are at least 18 years old - Women who identify as Black/African American or Hispanic - Women whose average seated systolic blood pressure measured at least 130 mmHg during an initial screening at a participating salon - Women who have visited one of the participating sa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07044232 · Aarhus University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 September 2026
🇩🇰 DK

**Who might be able to join this trial:** - You must be 18 years old or older - You must have been diagnosed with a brain bleed (bleeding inside the brain that happened on its own, not from an outside cause), confirmed by a brain scan - You must have arrived at a stroke centre within 6 hours of your symptoms starting -...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07049783 · Freda Patterson Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 39 years old - People whose resting blood pressure falls within a specific range — at or above 120/80 mmHg but below 140/90 mmHg (sometimes called "elevated" or "stage 1" blood pressure — confirm with trial site if unsure where your reading falls) **Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07070583 · Rijnstate Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇳🇱 NL

Who might be able to join this trial: - People who are 18 years of age or older - People who are willing and able to sign a consent form agreeing to take part - People who have a long-term (chronic) blockage in the main abdominal artery (below the kidneys) and/or one or both of the large arteries leading into the legs...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07076303 · Brian Shafer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - You have recently been diagnosed with open-angle glaucoma and have not yet received any treatment for it (no eye drops, medications, or surgery) - You have been diagnosed with a related eye condition such as high eye pressure (ocular hyperte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07098975 · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2027
🇪🇸 ES

Who might be able to join this trial: - People who are pregnant with a single baby (not twins or more). - People who are between 24 weeks and 29 weeks and 6 days pregnant at the time of joining the trial. - People who have been diagnosed with severe early-onset pre-eclampsia (a serious pregnancy complication involving...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07099677 · Abant Izzet Baysal University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People aged between 18 and 75 years - People who have recently been diagnosed with high blood pressure (hypertension) for the first time - People who have not previously taken any medication to lower blood pressure - People with no history of neurological, inner ear, bone/joi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07106294 · Heidelberg University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇩🇪 DE

Who might be able to join this trial: - People who are pregnant with one baby (not twins or more) - People who are 18 years of age or older - People who are able to understand and agree to take part in the study - People who are able to sign a written consent form - People who are already scheduled for a routine ultras...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07109739 · University of Minnesota Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People whose resting blood pressure (the top number) measured at least 120 mmHg at two separate screening appointments - People who are free from serious heart, blood vessel, or metabolic diseases, based on self-reported health histor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07116096 · Shanxi Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 August 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been clinically diagnosed with liver cirrhosis (scarring of the liver) - People whose endoscopy (a camera procedure to look inside the digestive tract) has confirmed the presence of enlarged veins (varices) in the esophagus or s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07125313 · Universidade Federal de Santa Catarina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 December 2026
🇧🇷 BR

**Who might be able to join this trial:** - Adults aged 40 years or older - Both men and women are eligible - People who have been diagnosed with high blood pressure that is managed with up to three medications - People who are not considered to be at high cardiovascular risk (confirm with trial site) - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07135505 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are willing to give their consent to take part in the study - Men and women aged 60 or older - People whose average blood pressure reading (top number) taken at a clinic or doctor's office is 130 mmHg or higher - People who currently eat across a period of 12 or mo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07142356 · Retension Pharmaceuticals. Inc. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 October 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have given written agreement to participate before any study procedures begin - People aged 18 to 70 years old at the time of their screening visit - People with high blood pressure that is not well controlled, even though they are already taking at least 2 differ...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07158047 · University of Oregon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

Who might be able to join this trial: - People with a body mass index (BMI) between 30 and 45, which is a measure of body weight relative to height Who may not be able to join: - People who have been diagnosed with diabetes - People with high blood pressure that is classed as higher than stage 2 (confirm with trial si...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07163676 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇪🇬 EG

Who might be able to join this trial: - People who have been diagnosed with high-tension primary open-angle glaucoma in both eyes (a type of glaucoma where fluid pressure in the eye is higher than normal and affects both eyes) - People who have elevated pressure inside both eyes (a condition called ocular hypertension)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07174622 · Medtronic Vascular Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇺🇸 US

Who might be able to join this trial: - You are currently enrolled in a Medicare health insurance plan - You have been diagnosed with high blood pressure that is not well controlled - You are already taking blood pressure medication and your dose has been stable for a period of time Who may not be able to join: - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07177989 · Foundation University Islamabad Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 January 2026
🇵🇰 PK

Who might be able to join this trial: - Adults between the ages of 25 and 50 years old, both male and female - People who have been diagnosed with stage 1 high blood pressure (readings of 130–139 / 80–89 mmHg) or stage 2 high blood pressure (readings of 140/90 mmHg or higher), based on American Heart Association guidel...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07178600 · Instituto de Oftalmología Fundación Conde de Valenciana Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇲🇽 MX

Who might be able to join this trial: - People who have given their written agreement to take part in the study by signing a consent form. - People who are older than 18 years of age. - People of any sex. - People who are patients at the "Instituto de Oftalmología Conde de Valenciana, IAP., sede Centro" and have been s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07183384 · Universitas Padjadjaran Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
🇮🇩 ID

Who might be able to join this trial: - People who have recently given birth - People who were diagnosed with preeclampsia (a pregnancy complication involving high blood pressure) during their most recent pregnancy - People who are within the first or second week after giving birth - People who are able to give their o...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07185204 · Medical College of Wisconsin Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
Nepal🇺🇸 US

**Who might be able to join this trial:** - People who are pregnant and at 36 weeks or more along in their pregnancy, with no major problems detected with the baby - People who are 18 years of age or older - People who are admitted for labour at Dhulikhel Hospital, or who plan to give birth at Dhulikhel Hospital - Peo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07193680 · Hospital Universitari Vall d'Hebron Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇪🇸 ES

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are pregnant with one baby (not twins or more) - People who have been diagnosed with a milder form of preeclampsia (high blood pressure in pregnancy without serious warning signs), based on a specific medical definition - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07194733 · VA Eastern Colorado Health Care System Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older - People who have been diagnosed with chronic kidney disease at stage 3b or stage 4 (a moderate-to-severe level of kidney disease, but not yet on dialysis or having had a transplant) - People who have screened positive for food insecurity (meaning there ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07201948 · Meharry Medical College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2027
🇺🇸 US

Who might be able to join this trial: - People who live in Davidson County or the surrounding counties in Tennessee. - People who are at least 30 years old. - People who are at increased risk of developing high blood pressure — either because they have already been diagnosed or because close family members have had it....

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07206030 · University Hospital, Grenoble Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇫🇷 FR

Who might be able to join this trial: - Adults over 18 years old who have high blood pressure and have been treated with a procedure called renal denervation (RDN) in France, regardless of which device was used or the reason for the procedure - People who received renal denervation in the past may also be included, as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07209254 · Jennifer Lewey, MD, MPH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2029
🇺🇸 US

Who might be able to join this trial: - You are 18 years old or older - You gave birth within the last 14 days - You were diagnosed with high blood pressure related to pregnancy (called preeclampsia or gestational hypertension) either during pregnancy or within 14 days after giving birth - You were prescribed blood pre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07218783 · SpyGlass Pharma, Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 March 2029
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with mild to moderate open-angle glaucoma or high eye pressure (ocular hypertension) - You are planning to have cataract removal surgery - If you are a woman who could become pregnant, you must have a negative pregnancy test at the start of the trial and a...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07222917 · AstraZeneca Phase 2 · 11 countries Recruiting
Recruiting Phase 2 Est. completion 24 May 2027
🇦🇷 AR🇧🇬 BG🇨🇦 CA🇰🇷 KR🇪🇸 ES🇹🇼 TW🇹🇭 TH Turkey (Türkiye) +3 more

**Who might be able to join this trial:** - Adults aged 18 or older at the time of signing the consent form - People whose kidneys are working at a reduced but not severely low level, based on a specific kidney function test result (eGFR between 30 and 90) at screening - People with a certain level of protein in their...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07228221 · Jonathon Myers Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 August 2031
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with moderate to severe open-angle glaucoma (including common types such as primary open-angle glaucoma, pigmentary glaucoma, or pseudoexfoliation glaucoma) - The drainage angle in your eye is open and has a normal structure (confirm with trial site) -...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07229196 · Unidad Enfermedades Cardiometabolicas- Hospital Interzonal General Agu... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇦🇷 AR

**Who might be able to join this trial:** - People between 30 and 59 years old (any sex) who have high blood pressure (hypertension). - People who have been told they have high blood pressure and are currently taking medication for it — such as ACE inhibitors, ARBs, calcium channel blockers, thiazide diuretics, or beta...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07236125 · Yelda Kasımoğlu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People who have attended the Pediatric Nephrology Department at Istanbul University Faculty of Medicine - People between the ages of 10 and 18 - People who have been diagnosed with primary hypertension (high blood pressure that is not caused by another condition) - People whe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07238556 · University of Connecticut Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇺🇸 US

Who might be able to join this trial: **For patients:** - People who have not done planned, structured physical activity at a moderate level for 30 minutes or more, at least 3 days per week, over the past 3 months - Adults aged 18 to 64 years old - People who have at least one heart disease risk factor, such as obesit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07247058 · Johns Hopkins University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been found to have a condition called mild autonomous cortisol secretion (MACS), which means the body produces slightly too much of a hormone called cortisol — confirmed by a specific blood test after taking a small do...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07254481 · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 July 2026
🇨🇳 CN

Who might be able to join this trial: - People who are willing to take part voluntarily, understand what the study involves and any risks, sign a consent form, and agree to follow the study rules - People aged between 18 and 50 years old (inclusive) who are healthy volunteers - People whose Body Mass Index (BMI) is bet...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07259733 · Instituto Dante Pazzanese de Cardiologia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇧🇷 BR

**Who might be able to join this trial:** - You are between 18 and 75 years old - You are currently taking 3 to 5 different types of blood pressure medications, including the highest recommended dose of a specific type called an ACE inhibitor or ARB, plus a water pill (diuretic), and a calcium channel blocker - A 24-ho...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07267260 · King Edward Medical University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 January 2026
🇵🇰 PK

**Who might be able to join this trial:** - Adults between 18 and 75 years old (any gender) - People who have been diagnosed with liver cirrhosis (scarring of the liver), confirmed through medical tests, blood work, or scans - People who have enlarged veins in the food pipe (esophageal varices) that have been identifie...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07280390 · Post Graduate Institute of Medical Education and Research, Chandigarh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2027
🇮🇳 IN

Who might be able to join this trial: - Adults between 18 and 70 years of age - People who have been diagnosed with cirrhosis (scarring of the liver), confirmed through a liver tissue sample or through a combination of clinical assessment, blood tests, and ultrasound findings - People who are scheduled for a planned (n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07282145 · Bichedam Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 23 September 2025
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 19 years or older at the time of the screening visit. - People who weigh at least 50 kg and have a body mass index (BMI) between 18.0 and 30.0 at screening (BMI is a measure calculated from height and weight). - People with no ongoing or long-term medical conditi...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07288801 · Nishtar Medical University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 8 February 2026
🇵🇰 PK

**Who might be able to join this trial:** - You are at least 20 weeks pregnant (based on the date of your last menstrual period) - You have a personal history of pre-eclampsia (a pregnancy condition involving high blood pressure) from a previous pregnancy **Who may not be able to join:** - You have a pre-existing cond...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07290842 · Gødstrup Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇩🇰 DK

Who might be able to join this trial: - People who have high blood pressure that is either newly diagnosed or being managed with no more than 2 blood pressure medications, with blood pressure readings within specific ranges at the screening visit. - People who have a type of chronic kidney disease (stages 1 to 3) cause...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07297797 · Fujian Shengdi Pharmaceutical Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who are willing to voluntarily sign a consent form agreeing to take part - People aged 18 to 75 years old (male or female) - People who have been diagnosed with mild to moderate high blood pressure - People whose sitting blood pressure reading in the clinic is above 13...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07298356 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are coming in for a routine eye exam - People who are 18 years of age or older - People who are able and willing to give their consent to participate Who may not be able to join: - People who have a history of scarring on the cornea (the clear front surface of the eye...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07304466 · Istanbul Medipol University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2027
Turkey (Türkiye)

Who might be able to join this trial: - People who are scheduled to receive a liver transplant using the right lobe of a liver donated by a living person, and who have significant complications from high blood pressure in the liver's main blood vessel — such as swollen veins in the food pipe, a low platelet count (unde...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07339852 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇨🇦 CA

Who might be able to join this trial: - You are 18 years old or older - You have been diagnosed with type 2 diabetes - Your blood sugar levels (measured by a test called HbA1c) are not well controlled and are above the target level of 7.0% Who may not be able to join: - You have type 1 diabetes, gestational diabetes (...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07341763 · University of Waterloo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇨🇦 CA

**Who might be able to join this trial:** - You are a healthy adult (18 or older) who has narrowed/tunnel vision in both eyes caused by retinitis pigmentosa, rod-cone dystrophy, or advanced glaucoma. - Your vision, even with glasses or contact lenses, is no worse than 20/40, and your field of vision is no wider than 5...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07356518 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who were diagnosed with chronic high blood pressure before becoming pregnant - People who are currently pregnant - People whose chronic high blood pressure is confirmed through official medical records or who were already taking blood pressure medication before their pregn...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07356817 · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇪🇸 ES

Who might be able to join this trial: - You must have previously taken part in one of three specific research studies: the BiSC (Barcelona Life Study Cohort), EuroPE, or AngioCor studies. - You must have given birth within the last 3 to 6 years. - You must be willing to sign a written consent form agreeing to take part...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07358650 · Hexiris Inc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 February 2027
🇨🇦 CA

**Who might be able to join this trial:** - You are 40 years old or older and have mild to moderate open-angle glaucoma that is not well controlled - Your eye pressure is 18 mmHg or higher, even while using at least one eye drop medication to lower it - Your eye examination shows an open drainage angle in the eye (con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07361276 · AstraZeneca Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇧🇷 BR

Who might be able to join this trial: - People who were 18 years old or older when they were first diagnosed with high blood pressure - People who have a recorded diagnosis of high blood pressure in their medical records (using standard medical codes), OR who have had at least two blood pressure readings of 140/90 mmHg...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07361679 · Alexandra Hospital, Athens, Greece Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 August 2026
🇬🇷 GR

**Who might be able to join this trial:** - People who are pregnant with one baby (not twins or more) - People whose pregnancy screening results — including an ultrasound, blood tests, and medical history from the first trimester — show a greater than 1 in 150 chance of developing a serious blood pressure condition cal...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07363343 · The Cleveland Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇺🇸 US

Who might be able to join this trial: - Women aged 18 or older who have recently given birth - People who have been diagnosed with a blood pressure condition during pregnancy, such as gestational hypertension, chronic hypertension, or preeclampsia (with or without severe features) - People currently taking Nifedipine 6...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07397754 · Singapore Institute of Food and Biotechnology Innovation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 September 2026
🇸🇬 SG

Who might be able to join this trial: - People aged 50 years or older, but under 75 years old - Men, or women who have gone through menopause (based on self-report) - People who weigh at least 50 kg - People whose blood pressure readings fall within a specific elevated range — either a top number between 130 and 159, o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07400549 · China National Center for Cardiovascular Diseases Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 or older. - People who are willing to take part and can sign a consent form. - People who have been diagnosed with at least one of the following four conditions: high blood pressure (where blood pressure readings are consistently high, or where four or more bl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07405723 · Sheba Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇮🇱 IL

**Who might be able to join this trial:** - Pregnant women between 18 and 55 years of age - Those carrying one baby or more than one baby, where the pregnancy is confirmed to be ongoing and within the uterus - Those who are at any stage of pregnancy (first, second, or third trimester) at the time of joining the trial -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07408154 · Medical University of South Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇺🇸 US

Who might be able to join this trial: - People aged 18 years or older - People who have been diagnosed with open-angle glaucoma (including types related to exfoliation or pigment) or high eye pressure without glaucoma (called ocular hypertension) - People whose eye drainage angle is fully open when examined by a specia...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07413159 · Texas Southern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2028
🇺🇸 US

Who might be able to join this trial: - People aged 55 years or older - People who have had at least 2 high blood pressure readings of 130/80 or higher within the past month - People who have been diagnosed with high blood pressure for more than 1 year - People who are currently taking at least one medication to lower...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07424963 · Military University Hospital, Prague Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇿 CZ

**Who might be able to join this trial:** - People between 18 and 75 years of age at the time of enrolling in the trial - People who have a medical reason to undergo a specific procedure to measure pressure in the liver's blood vessels, or to have a liver tissue sample taken through the neck vein, due to long-term seri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07425535 · Johns Hopkins University Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 March 2028
🇺🇸 US

**Who might be able to join this trial:** - Adults aged over 30 of any sex or ethnic background may be considered. - People who have no history of open-angle glaucoma (a specific type of eye pressure condition) may be considered. - People whose eye examination by a glaucoma specialist showed no signs of open-angle gla...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT07432126 · Kathmandu University School of Medical Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
Nepal

Who might be able to join this trial: - People who are 30 years of age or older - People who have high blood pressure (at or above 140/90 mmHg) or are currently taking medication for high blood pressure - People who have a blood sugar level (measured by a test called HbA1c) of 6.5% or higher, or are currently taking me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07432893 · Sarah Nabia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2026
🇮🇳 IN

**Who might be able to join this trial:** - Adults aged 18 years or older - People attending one of the participating primary care clinics involved in the study - People who have been diagnosed with high blood pressure (hypertension) - People who have been diagnosed with diabetes, or whose blood test results indicate d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07439939 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 June 2027
🇫🇷 FR

Who might be able to join this trial: - You must be 18 years old or older and covered by a social security (health insurance) scheme, or be a dependent of someone who is - You must be a patient being treated for cirrhosis (liver scarring) at Paul Brousse Hospital and be scheduled to have a procedure called a TIPS (a sm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07440277 · University of Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 August 2027
🇬🇧 GB

**Who might be able to join this trial:** - People who have been diagnosed with Idiopathic Intracranial Hypertension (IIH) according to established medical guidelines, with swelling at the back of the eye (papilloedema) and a risk of vision loss - People who have a certain level of eye swelling (graded 3 or higher on...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07443345 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇪🇬 EG

Who might be able to join this trial: - People who have been diagnosed with severe preeclampsia (a serious pregnancy complication involving high blood pressure) and are having a caesarean section - People who are more than 32 weeks pregnant Who may not be able to join: - People who are under 20 years of age - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07444138 · São Paulo State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇧🇷 BR

Who might be able to join this trial: - Women between the ages of 60 and 70 years old. - People who do not have health conditions that would prevent them from safely completing the physical exercise tests required by the trial. Who may not be able to join: - People who currently smoke. - People who have a history of a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07453550 · University of Hartford Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 55 years old - Your average blood pressure over 24 hours is above 110/70 but the top number (systolic) is below 160 - You are able to read, understand, and sign a consent form agreeing to take part **Who may not be able to join:** - You are currently t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07457970 · University of South Carolina Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 July 2029
🇺🇸 US

Who might be able to join this trial: - People who are at least 28 weeks pregnant - People who have been diagnosed with a hypertensive disorder related to pregnancy, or who have chronic high blood pressure - People who are pregnant with a single baby (not twins or more) - People who have access to a phone - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07460791 · Johannes Gutenberg University Mainz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇩🇪 DE

Who might be able to join this trial: - People who previously took part in one of the following trials at the clinical trial site in Mainz: the HYDRUS I trial, the HYDRUS II trial, the HYDRUS IV trial, or the SPECTRUM data collection - People who, during their previous trial, either had the Hydrus implant placed at the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07461415 · Weill Medical College of Cornell University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2029
🇵🇰 PK

Who might be able to join this trial: - Adults aged 18 years or older - People who arrive at the emergency department with a high blood pressure reading (top number above 180 and/or bottom number above 110), confirmed by a second similar reading taken at least 30 minutes later - People who may have already received som...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07461545 · Northern Jiangsu People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with cirrhosis (scarring of the liver) of any cause, confirmed by clinical assessment, imaging, or tissue sample. - People who have an enlarged spleen that has caused a reduction in blood cell counts (a condition called hypersplenism). - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07464379 · Second Affiliated Hospital of Wenzhou Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇳 CN

Who might be able to join this trial: - Healthy pregnant women may be eligible to join - People who have experienced a miscarriage may also be considered (confirm with trial site for full details on what conditions are included under "etc.") Who may not be able to join: - Pregnant women who have a heart condition may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07465913 · Eye Centers of Southeast Texas Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 6 May 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years old or older and have been diagnosed with mild to moderate glaucoma (specifically a type called open-angle glaucoma) affecting both eyes - You are currently using 3 eye drop medications for glaucoma, and at least one of them must be a type called a prostagla...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07469800 · Innovent Biologics (Suzhou) Co. Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 August 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older at the time of signing the consent form. - People who have been diagnosed with high blood pressure (hypertension). - People who have either never taken blood pressure medication, or who previously took only one type of blood pressure medication at a t...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07470320 · University of Oxford Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2030
🇬🇧 GB

Who might be able to join this trial: - Women aged 18 or older - People who are willing and able to give their formal agreement to take part in the study - People who can read and understand written and spoken English well enough to understand the study materials and give informed consent - Women who are not pregnant a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07482020 · Huashan Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - People between 18 and 80 years old who are receiving care (either as outpatients or inpatients) at one of the research centres and are included in the centre's atrial fibrillation (irregular heartbeat) database. - People who have been confirmed to have a type of irregular hea...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07504055 · University of Louisville Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2029
🇺🇸 US

**Who might be able to join this trial:** - People who are at least 18 years old - People whose overall health condition is stable - People who have a spinal cord injury (SCI) that has not gotten worse neurologically since at least 6 months after the injury, or in the 6 months before screening - People whose spinal co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07512609 · Qifu Li Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - Anyone who chooses to take part in a physical health check-up on a voluntary basis Who may not be able to join: - People whose health or personal information records are incomplete or missing important details Important: Always verify eligibility with the trial site directly be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07513558 · Medical University of Graz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2031
🇦🇹 AT

Who might be able to join this trial: - People who are currently pregnant and have been diagnosed with preeclampsia (a pregnancy complication involving high blood pressure), at any stage of the pregnancy Who may not be able to join: - People whose pregnancy involves a genetic abnormality in either the mother or the ba...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07517302 · Peking University People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who are 40 years of age or older - People who have been diagnosed with a specific type of glaucoma called chronic primary angle-closure glaucoma (CPACG), confirmed by eye examination showing a certain pattern of eye changes alongside damage to the optic nerve and visio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07531966 · University of Aarhus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2031
🇩🇰 DK

Who might be able to join this trial: - People who have had a kidney transplant and are experiencing a significant drop in how well the transplanted kidney is filtering blood, where other causes such as rejection, blockage, or infection have been ruled out. - People who had a transplanted kidney that was filtering bloo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07534501 · Institute for Medical Research, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇺🇸 US

Who might be able to join this trial: - People who are at risk of not having reliable access to enough food - People who have high blood pressure AND also have either diabetes or obesity - People who have had a hospital stay, an emergency department visit, or an outpatient medical appointment in the past 12 months - Pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07540143 · Northwestern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2029
🇺🇸 US

Who might be able to join this trial: - People who are biologically female - People between the ages of 18 and 44 - People who speak English or Spanish - People who have been prescribed a blood pressure-lowering medication - People whose blood pressure was recorded above a certain level (systolic above 140 or diastolic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07547345 · Rush University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People who have had two separate blood pressure readings recorded on two different days within the past 3 months, where the top number (systolic) was above 130 on both occasions Who may not be able to join: - People who are currently receiving dia...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07552571 · Xiong Juyang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇨🇳 CN

Who might be able to join this trial: - People who have been living in the study area for at least 1.5 years - People who have been diagnosed with at least one of the following long-term health conditions: high blood pressure, diabetes, or high cholesterol/fats in the blood - People who are alert and able to hold a con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07553442 · Alnylam Pharmaceuticals Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 April 2028
🇺🇸 US

**Who might be able to join this trial:** **Part A:** - Adults whose average seated blood pressure reading (the top number) is between 130 and 170 mmHg when measured in a clinic - People who are either not taking any blood pressure medication, or who have been on a steady dose of up to 2 blood pressure medications **...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07565727 · University of Tennessee Graduate School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 45 years old - Pregnant people at any pre-pregnancy body weight or size - People who have at least one high-risk factor, or at least one moderate-risk factor, for a pregnancy complication called pre-eclampsia, based on recognised medical guidelines (confirm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07583940 · North Carolina Agriculture & Technical State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2027
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 25 years old - Both male and female participants are welcome - People who are Division I collegiate athletes at an HBCU (Historically Black College or University) with more than 3 years of previous competitive sports experience Who may not be able t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07596966 · Universidade Federal Fluminense Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 December 2026
🇧🇷 BR

Who might be able to join this trial: - People who have been diagnosed with stage 1 or stage 2 high blood pressure - People who have been receiving regular treatment for their high blood pressure for more than 6 months - People whose blood pressure medication doses have not changed in the last three months Who may not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07601308 · Alexandria University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 years or older - People who have had their condition for at least 6 months - People who use social media at least once a week - People who are able to give their formal agreement to take part in the study Who may not be able to join: - People who have a severe cog...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07606859 · University of Cyprus Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
Cyprus🇪🇸 ES

**Who might be able to join this trial:** - People aged 65 or older - People living in the Barcelona (Spain) or Nicosia (Cyprus) metropolitan areas - People who have been diagnosed with high blood pressure by a doctor - People who take daily medication to manage their blood pressure - People whose health condition is c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07607795 · University of Poitiers Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇫🇷 FR

Who might be able to join this trial: - Pregnant women who are covered by the French National Health Insurance system. - Pregnant women who do not object to taking part in the study. - Pregnant women who had high blood pressure before becoming pregnant (diagnosed in the last 5 years), with readings of 140 or higher for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07614399 · Charles University, Czech Republic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2029
🇨🇿 CZ

Who might be able to join this trial: - People who have developed a fluid-filled swelling under the scalp (called a pseudomeningocele) after planned, non-emergency brain surgery - People who are willing and able to give their agreement to take part in the trial - People who have not had any previous surgery on the brai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07648706 · Sana'a University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
Yemen

Who might be able to join this trial: - Women who are pregnant with one baby (not twins or more) - Women who are between 8 and 18 weeks pregnant - Women whose blood test shows low vitamin D levels (specifically below 25 ng/mL) - Women who are willing and able to sign a written consent form agreeing to take part - Women...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07665034 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
Hong Kong

Who might be able to join this trial: - Adults who have no symptoms and whose condition is considered medically stable - People aged between 18 and 75 years - People of any gender - People with blood pressure that is not fully controlled (while already on stable blood pressure medication), with a systolic blood pressur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07683585 · National Medical Research Center for Therapy and Preventive Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇷🇺 RU

Who might be able to join this trial: - People who are between 50 and 70 years old - People who have been diagnosed with high blood pressure - People who have been diagnosed with coronary artery disease (a condition where the arteries supplying the heart become narrowed) - People who are admitted to hospital for a plan...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07688928 · Bangladesh Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
Bangladesh

**Who might be able to join this trial:** - People who are older than 18 years of age - People who have high blood pressure (readings above 140/90 mmHg), whether newly found or already known - People who have been diagnosed with a condition called primary aldosteronism (a hormone-related cause of high blood pressure),...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07713056 · Zhongnan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇨🇳 CN

Who might be able to join this trial: - People diagnosed with pigmentary glaucoma, showing typical signs such as pigment dispersion in the eye, significant pigment buildup in the eye's drainage tissue, raised eye pressure, damage to the optic nerve, and specific changes in vision - People whose first and only surgical...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Hypertension. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

The Heart Foundation covers high blood pressure as part of its work on heart health.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.